Marvell Technology (MRVL) 10-Q4 Dec 242025 Q3 Quarterly reportFinancial data

Company Profile

Cover

Cover - shares shares in Millions	9 Months Ended
Cover - shares shares in Millions	Nov. 02, 2024	Nov. 27, 2024
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Nov. 02, 2024
Document Transition Report	false
Entity File Number	001-40357
Entity Registrant Name	MARVELL TECHNOLOGY, INC
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	85-3971597
Entity Address, Address Line One	1000 N. West Street, Suite 1200
Entity Address, City or Town	Wilmington
Entity Address, State or Province	DE
Entity Address, Postal Zip Code	19801
City Area Code	302
Local Phone Number	295-4840
Title of 12(b) Security	Common Stock, par value $0.002 per share
Trading Symbol	MRVL
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		865.3
Amendment Flag	false
Document Fiscal Year Focus	2025
Document Fiscal Period Focus	Q3
Entity Central Index Key	0001835632
Current Fiscal Year End Date	--02-01

UNAUDITED CONDENSED CONSOLIDATE

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Nov. 02, 2024	Feb. 03, 2024
Current assets:
Cash and cash equivalents	$ 868.1	$ 950.8
Accounts receivable, net	997.9	1,121.6
Inventories	859.4	864.4
Prepaid expenses and other current assets	91.4	125.9
Total current assets	2,816.8	3,062.7
Property and equipment, net	781.9	756
Goodwill	11,586.9	11,586.9
Acquired intangible assets, net	2,957.7	4,004.1
Deferred tax assets	406.5	311.9
Other non-current assets	1,165.8	1,506.9
Total assets	19,715.6	21,228.5
Current liabilities:
Accounts payable	538.1	411.3
Accrued liabilities	825.2	1,032.9
Accrued employee compensation	270.9	262.7
Short-term debt	129.4	107.3
Total current liabilities	1,763.6	1,814.2
Long-term debt	3,965.5	4,058.6
Other non-current liabilities	613.6	524.3
Total liabilities	6,342.7	6,397.1
Commitments and contingencies (Note 8)
Stockholders’ equity:
Common stock, $0.002 par value	1.7	1.7
Additional paid-in capital	14,629	14,845.3
Accumulated other comprehensive income (loss)	(0.3)	1.1
Accumulated deficit	(1,257.5)	(16.7)
Total stockholders’ equity	13,372.9	14,831.4
Total liabilities and stockholders’ equity	$ 19,715.6	$ 21,228.5

UNAUDITED CONDENSED CONSOLIDA_2

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Nov. 02, 2024	Feb. 03, 2024
Statement of Financial Position [Abstract]
Common stock, par value (in dollars per share)	$ 0.002	$ 0.002

UNAUDITED CONDENSED CONSOLIDA_3

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Nov. 02, 2024	Oct. 28, 2023	Nov. 02, 2024	Oct. 28, 2023
Income Statement [Abstract]
Net revenue	$ 1,516.1	$ 1,418.6	$ 3,949.9	$ 4,081.2
Cost of goods sold	1,166.7	867.4	2,485.1	2,451.7
Gross profit	349.4	551.2	1,464.8	1,629.5
Operating expenses:
Research and development	488.6	481.1	1,451.4	1,436.6
Selling, general and administrative	205.3	213	602.5	622
Restructuring related charges	358.3	3.4	366.4	105.3
Total operating expenses	1,052.2	697.5	2,420.3	2,163.9
Operating loss	(702.8)	(146.3)	(955.5)	(534.4)
Interest expense	(47.2)	(52.6)	(144.4)	(159.1)
Interest income and other, net	(0.5)	11.4	5.4	22.1
Interest and other loss, net	(47.7)	(41.2)	(139)	(137)
Loss before income taxes	(750.5)	(187.5)	(1,094.5)	(671.4)
Benefit from income taxes	(74.2)	(23.2)	(9.3)	(130.7)
Net loss	$ (676.3)	$ (164.3)	$ (1,085.2)	$ (540.7)
Net loss per share — basic (in dollars per share)	$ (0.78)	$ (0.19)	$ (1.25)	$ (0.63)
Net loss per share — diluted (in dollars per share)	$ (0.78)	$ (0.19)	$ (1.25)	$ (0.63)
Weighted-average shares:
Basic (in shares)	865.7	862.6	865.5	860.1
Diluted (in shares)	865.7	862.6	865.5	860.1

UNAUDITED CONDENSED CONSOLIDA_4

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Nov. 02, 2024	Oct. 28, 2023	Nov. 02, 2024	Oct. 28, 2023
Statement of Comprehensive Income [Abstract]
Net loss	$ (676.3)	$ (164.3)	$ (1,085.2)	$ (540.7)
Other comprehensive income (loss), net of tax
Net change in unrealized gain (loss) on cash flow hedges	0.1	(0.4)	(1.4)	(1.4)
Other comprehensive income (loss), net of tax	0.1	(0.4)	(1.4)	(1.4)
Comprehensive loss, net of tax	$ (676.2)	$ (164.7)	$ (1,086.6)	$ (542.1)

UNAUDITED CONDENSED CONSOLIDA_5

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) shares in Millions, $ in Millions	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income (Loss)	Retained Earnings (Accumulated Deficit)
Balance at beginning of period (in shares) at Jan. 28, 2023		856.1
Balance at beginning of period at Jan. 28, 2023	$ 15,637.2	$ 1.7	$ 14,512	$ 0	$ 1,123.5
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock in connection with equity incentive plans (in shares)		3.8
Issuance of common stock in connection with equity incentive plans	8.3		8.3
Tax withholdings related to net share settlement of restricted stock units	(72.6)		(72.6)
Stock-based compensation	142.2		142.2
Cash dividends declared and paid	(51.4)				(51.4)
Net loss	(168.9)				(168.9)
Other comprehensive income (loss)	(0.9)			(0.9)
Balance at end of period (in shares) at Apr. 29, 2023		859.9
Balance at end of period at Apr. 29, 2023	15,493.9	$ 1.7	14,589.9	(0.9)	903.2
Balance at beginning of period (in shares) at Jan. 28, 2023		856.1
Balance at beginning of period at Jan. 28, 2023	$ 15,637.2	$ 1.7	14,512	0	1,123.5
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Repurchase of common stock (in shares)	(0.8)
Repurchase of common stock	$ (50)
Net loss	(540.7)
Other comprehensive income (loss)	(1.4)
Balance at end of period (in shares) at Oct. 28, 2023		864.3
Balance at end of period at Oct. 28, 2023	15,233.4	$ 1.7	14,805.2	(1.4)	427.9
Balance at beginning of period (in shares) at Apr. 29, 2023		859.9
Balance at beginning of period at Apr. 29, 2023	15,493.9	$ 1.7	14,589.9	(0.9)	903.2
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock in connection with equity incentive plans (in shares)		3.4
Issuance of common stock in connection with equity incentive plans	52.1		52.1
Tax withholdings related to net share settlement of restricted stock units	(51.2)		(51.2)
Stock-based compensation	154		154
Cash dividends declared and paid	(51.7)				(51.7)
Net loss	(207.5)				(207.5)
Other comprehensive income (loss)	(0.1)			(0.1)
Balance at end of period (in shares) at Jul. 29, 2023		863.3
Balance at end of period at Jul. 29, 2023	15,389.5	$ 1.7	14,744.8	(1)	644
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock in connection with equity incentive plans (in shares)		1.8
Issuance of common stock in connection with equity incentive plans	0.6		0.6
Tax withholdings related to net share settlement of restricted stock units	(44.9)		(44.9)
Stock-based compensation	$ 154.7		154.7
Repurchase of common stock (in shares)	(0.8)	(0.8)
Repurchase of common stock	$ (50)		(50)
Cash dividends declared and paid	(51.8)				(51.8)
Net loss	(164.3)				(164.3)
Other comprehensive income (loss)	(0.4)			(0.4)
Balance at end of period (in shares) at Oct. 28, 2023		864.3
Balance at end of period at Oct. 28, 2023	15,233.4	$ 1.7	14,805.2	(1.4)	427.9
Balance at beginning of period (in shares) at Feb. 03, 2024		865.5
Balance at beginning of period at Feb. 03, 2024	14,831.4	$ 1.7	14,845.3	1.1	(16.7)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock in connection with equity incentive plans (in shares)		2.2
Issuance of common stock in connection with equity incentive plans	2.2		2.2
Tax withholdings related to net share settlement of restricted stock units	(74.1)		(74.1)
Stock-based compensation	137.3		137.3
Repurchase of common stock (in shares)		(2.2)
Repurchase of common stock	(150)		(150)
Cash dividends declared and paid	(51.8)				(51.8)
Net loss	(215.6)				(215.6)
Other comprehensive income (loss)	(0.7)			(0.7)
Balance at end of period (in shares) at May. 04, 2024		865.5
Balance at end of period at May. 04, 2024	14,478.7	$ 1.7	14,760.7	0.4	(284.1)
Balance at beginning of period (in shares) at Feb. 03, 2024		865.5
Balance at beginning of period at Feb. 03, 2024	$ 14,831.4	$ 1.7	14,845.3	1.1	(16.7)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Repurchase of common stock (in shares)	(7.3)
Repurchase of common stock	$ (525)
Net loss	(1,085.2)
Other comprehensive income (loss)	(1.4)
Balance at end of period (in shares) at Nov. 02, 2024		865.2
Balance at end of period at Nov. 02, 2024	13,372.9	$ 1.7	14,629	(0.3)	(1,257.5)
Balance at beginning of period (in shares) at May. 04, 2024		865.5
Balance at beginning of period at May. 04, 2024	14,478.7	$ 1.7	14,760.7	0.4	(284.1)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock in connection with equity incentive plans (in shares)		3.2
Issuance of common stock in connection with equity incentive plans	49.3		49.3
Tax withholdings related to net share settlement of restricted stock units	(57.6)		(57.6)
Stock-based compensation	155.5		155.5
Repurchase of common stock (in shares)		(2.5)
Repurchase of common stock	(175)		(175)
Cash dividends declared and paid	(51.9)				(51.9)
Net loss	(193.3)				(193.3)
Other comprehensive income (loss)	(0.8)			(0.8)
Balance at end of period (in shares) at Aug. 03, 2024		866.2
Balance at end of period at Aug. 03, 2024	14,204.9	$ 1.7	14,732.9	(0.4)	(529.3)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock in connection with equity incentive plans (in shares)		1.6
Issuance of common stock in connection with equity incentive plans	0.9		0.9
Tax withholdings related to net share settlement of restricted stock units	(58.6)		(58.6)
Stock-based compensation	$ 153.8		153.8
Repurchase of common stock (in shares)	(2.6)	(2.6)
Repurchase of common stock	$ (200)		(200)
Cash dividends declared and paid	(51.9)				(51.9)
Net loss	(676.3)				(676.3)
Other comprehensive income (loss)	0.1			0.1
Balance at end of period (in shares) at Nov. 02, 2024		865.2
Balance at end of period at Nov. 02, 2024	$ 13,372.9	$ 1.7	$ 14,629	$ (0.3)	$ (1,257.5)

UNAUDITED CONDENSED CONSOLIDA_6

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical) - $ / shares	3 Months Ended
	Nov. 02, 2024	Aug. 03, 2024	May 04, 2024	Oct. 28, 2023	Jul. 29, 2023	Apr. 29, 2023
Statement of Stockholders' Equity [Abstract]
Cash dividends declared (in dollars per share)	$ 0.06	$ 0.06	$ 0.06	$ 0.06	$ 0.06	$ 0.06
Cash dividends paid (in dollars per share)	$ 0.06	$ 0.06	$ 0.06	$ 0.06	$ 0.06	$ 0.06

UNAUDITED CONDENSED CONSOLIDA_7

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	9 Months Ended
	Nov. 02, 2024	Oct. 28, 2023
Cash flows from operating activities:
Net loss	$ (1,085.2)	$ (540.7)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	225.5	226
Stock-based compensation	449.8	454.5
Amortization of acquired intangible assets	805.5	811.6
Restructuring related impairment charges	524.1	32.2
Deferred income taxes	(106.2)	(283.7)
Other expense, net	42.1	39.9
Changes in assets and liabilities:
Accounts receivable	123.7	(22.4)
Prepaid expenses and other assets	176.2	14.4
Inventories	(60.2)	123.1
Accounts payable	109.8	(87.5)
Accrued employee compensation	11.9	0.7
Accrued liabilities and other non-current liabilities	(49.8)	55.8
Net cash provided by operating activities	1,167.2	823.9
Cash flows from investing activities:
Purchases of technology licenses	(6.2)	(3.3)
Purchases of property and equipment	(214.7)	(265.3)
Acquisitions, net of cash acquired	(10.4)	(5.5)
Other, net	0.9	(0.2)
Net cash used in investing activities	(230.4)	(274.3)
Cash flows from financing activities:
Repurchases of common stock	(525)	(50)
Proceeds from employee stock plans	52.4	61.1
Tax withholding paid on behalf of employees for net share settlement	(190.3)	(168.7)
Dividend payments to stockholders	(155.6)	(154.9)
Payments on technology license obligations	(124.4)	(110.2)
Proceeds from borrowings	0	1,295.3
Principal payments of debt	(76.6)	(1,600.6)
Other, net	0	(7)
Net cash used in financing activities	(1,019.5)	(735)
Net decrease in cash and cash equivalents	(82.7)	(185.4)
Cash and cash equivalents at beginning of period	950.8	911
Cash and cash equivalents at end of period	$ 868.1	$ 725.6

Basis of Presentation

Basis of Presentation	9 Months Ended
Basis of Presentation	Nov. 02, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	Basis of Presentation The unaudited condensed consolidated financial statements of Marvell Technology, Inc. (“MTI”), a Delaware corporation, and its wholly owned subsidiaries (the “Company”), as of and for the three and nine months ended November 2, 2024, have been prepared as required by the U.S. Securities and Exchange Commission (the “SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) have been condensed or omitted as permitted by the SEC. These unaudited condensed consolidated financial statements and related notes should be read in conjunction with the Company’s fiscal 2024 audited financial statements included in the Company’s Annual Report on Form 10-K for the fiscal year ended February 3, 2024. In the opinion of management, the financial statements include all adjustments, including normal recurring adjustments and other adjustments, that are considered necessary for fair presentation of the Company’s financial position and results of operations. All inter-company accounts and transactions have been eliminated. Operating results for the periods presented herein are not necessarily indicative of the results that may be expected for the entire year. Certain prior period amounts have been reclassified to conform to current period presentation. These financial statements should also be read in conjunction with the Company’s critical accounting policies included in the Company’s Annual Report on Form 10-K for the fiscal year ended February 3, 2024 and those included in this Quarterly Report on Form 10-Q below. All dollar amounts in the financial statements and tables in these notes, except per share amounts, are stated in millions of U.S. dollars unless otherwise noted. The Company’s fiscal year is the 52- or 53-week period ending on the Saturday closest to January 31. Accordingly, every fifth or sixth fiscal year will have a 53-week period. The additional week in a 53-week year is added to the fourth quarter, making such quarter consist of 14 weeks. Fiscal 2024 had a 53-week year. Fiscal 2025 is a 52-week year. Use of Estimates The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. On an ongoing basis, the Company evaluates its estimates, including those related to revenue recognition, provisions for sales returns and allowances, inventory excess and obsolescence, goodwill and other intangible assets, restructuring, income taxes, litigation and other contingencies. Actual results could differ from these estimates and such differences could affect the results of operations reported in future periods. In the current macroeconomic environment, these estimates could require increased judgment and carry a higher degree of variability and volatility. As events continue to evolve and additional information becomes available, these estimates may change materially in future periods.

Recent Accounting Pronouncement

Recent Accounting Pronouncements	9 Months Ended
Recent Accounting Pronouncements	Nov. 02, 2024
Accounting Changes and Error Corrections [Abstract]
Recent Accounting Pronouncements	Recent Accounting Pronouncements Accounting Pronouncements Not Yet Effective In November 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-07, Segment Reporting (Topic 280) to improve reportable segment disclosures. The update requires disclosure of incremental segment information on an annual and interim basis. The ASU is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, and requires retrospective application to all prior periods presented in the financial statements. Early adoption is permitted. The Company is evaluating the impact that this new standard will have on the Company’s consolidated financial statements disclosures. The Company does not expect the adoption of this new standard to have a material effect on the Company’s results of operations or financial condition. In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740) to improve income tax disclosures to enhance transparency and decision usefulness of income tax disclosure. The ASU is effective for fiscal years beginning after December 15, 2024 with updates to be applied on a prospective basis with the option to apply the standard retrospectively. Early adoption is permitted. The Company is evaluating the impact that this new standard will have on the Company’s consolidated financial statements.

Revenue

Revenue	9 Months Ended
Revenue	Nov. 02, 2024
Revenue from Contract with Customer [Abstract]
Revenue	Revenue Disaggregation of Revenue The majority of the Company’s revenue is generated from sales of the Company’s products. The following table summarizes net revenue disaggregated by end market (in millions, except percentages): Three Months Ended Nine Months Ended November 2, % of Total October 28, % of Total November 2, % of Total October 28, % of Total Net revenue by end market: Data center $ 1,101.1 73 % $ 555.8 39 % $ 2,798.4 71 % $ 1,451.4 36 % Enterprise networking 150.9 10 % 271.1 19 % 455.0 12 % 963.4 24 % Carrier infrastructure 84.7 6 % 316.5 22 % 232.4 6 % 881.9 22 % Consumer 96.5 6 % 168.7 12 % 227.4 6 % 478.5 12 % Automotive/industrial 82.9 5 % 106.5 8 % 236.7 5 % 306.0 6 % $ 1,516.1 $ 1,418.6 $ 3,949.9 $ 4,081.2 The following table summarizes net revenue disaggregated by primary geographical market based on destination of shipment (in millions, except percentages): Three Months Ended Nine Months Ended November 2, % of Total October 28, % of Total November 2, % of Total October 28, % of Total Net revenue based on destination of shipment: China $ 658.4 43 % $ 605.3 43 % $ 1,774.8 45 % $ 1,690.3 41 % United States 256.0 17 % 217.1 15 % 675.4 17 % 607.2 15 % Singapore 46.1 3 % 73.5 5 % 299.6 8 % 256.7 6 % Taiwan 198.5 13 % 22.9 2 % 279.6 7 % 135.8 3 % Thailand 73.3 5 % 94.5 7 % 233.3 6 % 215.9 5 % Malaysia 40.3 3 % 31.6 2 % 122.7 3 % 169.5 4 % Japan 55.8 4 % 37.5 3 % 106.3 3 % 125.4 3 % Finland 32.5 2 % 158.4 11 % 74.5 2 % 353.7 9 % Other 155.2 10 % 177.8 12 % 383.7 9 % 526.7 14 % $ 1,516.1 $ 1,418.6 $ 3,949.9 $ 4,081.2 These destinations of shipment are not necessarily indicative of the geographic location of the Company’s end customers or the country in which the Company’s end customers sell devices containing the Company’s products. For example, a substantial majority of the shipments made to China relate to sales to non-China based customers that have factories or contract manufacturing operations located within China. The following table summarizes net revenue disaggregated by customer type (in millions, except percentages): Three Months Ended Nine Months Ended November 2, % of Total October 28, % of Total November 2, % of Total October 28, % of Total Net revenue by customer type: Direct customers $ 895.4 59 % $ 937.6 66 % $ 2,229.2 56 % $ 2,685.7 66 % Distributors 620.7 41 % 481.0 34 % 1,720.7 44 % 1,395.5 34 % $ 1,516.1 $ 1,418.6 $ 3,949.9 $ 4,081.2 Contract Liabilities Contract liabilities consist of the Company’s obligation to transfer goods or services to a customer for which the Company has received consideration or the amount is due from the customer. Contract liability balances are comprised of deferred revenue. The amount of revenue recognized during the nine months ended November 2, 2024 that was included in the deferred revenue balance at February 3, 2024 was not material.

Restructuring

Restructuring	9 Months Ended
Restructuring	Nov. 02, 2024
Restructuring and Related Activities [Abstract]
Restructuring	Restructuring The Company continuously evaluates its existing operations to increase operational efficiency, decrease costs and increase profitability. Fiscal 2025 Plan A restructuring plan was initiated during the third quarter of fiscal 2025 (the “Fiscal 2025 Plan”) to increase research and development investment in the data center end market and reduce investment in new product development in other end markets including the cancellation of certain future product releases. As a result, the Company was required to assess the recoverability of related long-lived assets. On completion of the assessment, the Company determined the carrying values of certain long-lived assets were not recoverable. The Company utilized a discounted cash flow method of valuation to determine the fair value of the associated assets and liabilities and compared to their carrying values, which resulted in recognition of asset impairment charges for acquired intangible assets, purchased technology licenses, and property and equipment. The Company’s assumptions included future expected revenues, expenses, capital expenditures and other costs, discount rate, and whether or not alternative uses were available for affected assets. The Company recognized $715.1 million of total restructuring and other related charges for the three and nine months ended November 2, 2024 related to the Fiscal 2025 Plan. Restructuring charges were mainly comprised of impairment and write-off of acquired intangible assets, purchased technology licenses, inventories, property and equipment, and other non-current assets, as well as recognition of future contractual obligations, accrued legal reserve, severance, other one-time termination benefits, and other costs. The restructuring charges included $159.0 million impairment of capitalized purchased technology licenses that the Company has ceased use of in the third quarter of fiscal 2025. In addition, the Company recognized $97.8 million of restructuring charges related to payment obligations for future services associated with these technology licensing agreements. See “Note 8 – Commitments and Contingencies” for additional information. The Company expects the Fiscal 2025 Plan to be substantially completed by the end of fiscal 2026. Fiscal 2024 Plan A restructuring plan was initiated during the first quarter of fiscal 2024 (the “Fiscal 2024 Plan”) to streamline the organization and optimize resources. Restructuring charges were mainly comprised of severance, other one-time termination benefits, impairment and write-off of purchased technology licenses and equipment, and other costs. The Company recorded restructuring and other related charges of $8.1 million for the nine months ended November 2, 2024, and $3.4 million and $105.3 million for the three and nine months ended October 28, 2023, respectively, related to the Fiscal 2024 Plan. As of the third quarter of fiscal 2025, substantially all actions relating to the Fiscal 2024 Plan have been completed. The following table provides a summary of restructuring related charges as presented in the unaudited condensed consolidated statements of operations (in millions): Three Months Ended Nine Months Ended November 2, October 28, November 2, October 28, Restructuring related charges included in cost of goods sold $ 356.8 $ — $ 356.8 $ — Restructuring related charges included in operating expenses 358.3 3.4 366.4 105.3 Restructuring related charges included in net loss $ 715.1 $ 3.4 $ 723.2 $ 105.3 The following table presents details of the restructuring related charges as presented in the unaudited condensed consolidated statements of operations (in millions): Three Months Ended Nine Months Ended November 2, October 28, November 2, October 28, Employee severance and related costs $ 6.7 $ 3.0 $ 13.6 $ 69.1 Impairment and write-off of assets Acquired intangible assets 240.1 — 240.1 — Purchased technology licenses 159.0 — 159.0 28.6 Inventories 62.0 — 62.0 — Property and equipment 34.0 — 34.0 1.3 Other non-current assets 25.2 — 25.2 — Recognition of future contractual obligations 114.0 — 114.0 — Accrued legal reserve 50.0 — 50.0 — Other 24.1 0.4 25.3 6.3 $ 715.1 $ 3.4 $ 723.2 $ 105.3 The following table sets forth a reconciliation of the beginning and ending restructuring liability balances by major type of cost associated with the restructuring charges (in millions): Employee Severance and Related Costs Other Exit-Related Costs Total Balance at February 3, 2024 $ 15.5 $ 1.5 $ 17.0 Charges (1) 13.6 187.8 201.4 Net cash payments (22.3) (0.9) (23.2) Non-cash items (2) — 170.5 170.5 Balance at November 2, 2024 6.8 358.9 365.7 Less: non-current portion — 236.9 236.9 Current portion $ 6.8 $ 122.0 $ 128.8 (1) Impairment and other non-cash charges of $521.8 million recognized in the current quarter were recorded directly to the unaudited condensed consolidated statements of operations and were not included in the restructuring liability balances above. (2) Includes recognition of restructuring liabilities for future contractual obligations as a result of the cease use of related assets. The current portion of the restructuring liability is comprised of $120.8 million and $8.0 million included as components of accrued liabilities and accounts payable, respectively, and the non-current portion of the restructuring liability is included as a component of other non-current liabilities in the accompanying unaudited condensed consolidated balance sheets.

Goodwill and Acquired Intangibl

Goodwill and Acquired Intangible Assets, Net	9 Months Ended
Goodwill and Acquired Intangible Assets, Net	Nov. 02, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Acquired Intangible Assets, Net	Goodwill and Acquired Intangible Assets, Net Goodwill Goodwill represents the excess of the purchase price over the fair value of the net tangible and identifiable intangible assets acquired in a business combination. The carrying value of goodwill as of November 2, 2024 and February 3, 2024 was $11.6 billion. Acquired Intangible Assets, Net As of November 2, 2024 and February 3, 2024, net carrying amounts excluding fully amortized intangible assets were as follows (in millions, except for weighted-average remaining amortization period): November 2, 2024 Gross Carrying Amounts Accumulated Amortization and Impairment Net Carrying Amounts Weighted-Average Remaining Amortization Period (Years) Developed technologies $ 5,162.0 $ (3,296.6) $ 1,865.4 3.8 Customer contracts and related relationships 2,179.0 (1,437.4) 741.6 2.6 Trade names 50.0 (35.3) 14.7 1.5 Total acquired amortizable intangible assets $ 7,391.0 $ (4,769.3) $ 2,621.7 3.4 In-process research and development 336.0 — 336.0 n/a Total acquired intangible assets $ 7,727.0 $ (4,769.3) $ 2,957.7 The Company regularly assesses the results of its business to determine whether events or circumstances exist that indicate whether the carrying amount of the acquired intangible assets may not be recoverable. During the quarter ended November 2, 2024, impairment charges of $240.1 million related to certain acquired developed technologies intangible assets were recognized as part of restructuring actions. The gross carrying amounts and accumulated amortization of fully impaired intangible assets were excluded from the table above. See “Note 4 – Restructuring” for further information. February 3, 2024 Gross Carrying Amounts Accumulated Amortization Net Carrying Amounts Weighted-Average Remaining Amortization Period (Years) Developed technologies $ 4,989.0 $ (2,613.5) $ 2,375.5 3.8 Customer contracts and related relationships 2,179.0 (1,191.5) 987.5 3.3 Trade names 50.0 (27.9) 22.1 2.2 Total acquired amortizable intangible assets $ 7,218.0 $ (3,832.9) $ 3,385.1 3.6 In-process research and development 619.0 — 619.0 n/a Total acquired intangible assets $ 7,837.0 $ (3,832.9) $ 4,004.1 The intangible assets are amortized on a straight-line basis over the estimated useful lives, except for certain customer contracts and related relationships, which are amortized using an accelerated method of amortization over the expected customer lives, which more closely align with the pattern of realization of economic benefits expected to be obtained. The in-process research and development (“IPR&D”) will be accounted for as an indefinite-lived intangible asset and will not be amortized until the underlying project reaches technological feasibility and commercial production, at which point, the IPR&D is reclassified as an amortizable acquired intangible asset and amortized over the asset’s estimated useful life. Useful lives for these IPR&D projects are expected to range between 8 to 10 years. In the event the IPR&D is abandoned, the related assets will be written off. Amortization expense for acquired intangible assets for the three and nine months ended November 2, 2024 was $264.9 million and $805.5 million, respectively. Amortization expense for acquired intangible assets for the three and nine months ended October 28, 2023 was $269.8 million and $811.6 million , respectively. The following table presents the estimated future amortization expense of acquired amortizable intangible assets as of November 2, 2024 (in millions): Fiscal Year Amount Remainder of 2025 $ 247.0 2026 941.7 2027 811.3 2028 282.1 2029 129.0 Thereafter 210.6 $ 2,621.7

Fair Value Measurements

Fair Value Measurements	9 Months Ended
Fair Value Measurements	Nov. 02, 2024
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements Fair value is an exit price representing the amount that would be received in the sale of an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or a liability. As a basis for considering such assumptions, the accounting guidance establishes a three-tier value hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value: Level 1 — Observable inputs that reflect quoted prices for identical assets or liabilities in active markets. Level 2 — Other inputs that are directly or indirectly observable in the marketplace. Level 3 — Unobservable inputs that are supported by little or no market activity. The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The Company’s Level 1 assets include marketable equity investments that are classified as other non-current assets and which are valued primarily using quoted market prices. The Company’s Level 2 assets include time deposits, as the market inputs used to value these instruments consist of market yield. In addition, forward contracts and the severance pay fund are classified within Level 2 of the fair value hierarchy as the valuation inputs are based on quoted prices and market observable data of similar instruments. The tables below set forth, by level, the Company’s assets and liabilities that are measured at fair value on a recurring basis. The tables do not include assets and liabilities that are measured at historical cost or any basis other than fair value (in millions): Fair Value Measurements at November 2, 2024 Level 1 Level 2 Level 3 Total Items measured at fair value on a recurring basis: Assets Cash equivalents: Time deposits $ — $ 49.3 $ — $ 49.3 Other non-current assets: Marketable equity investments 9.3 — — 9.3 Severance pay fund — 0.5 — 0.5 Total assets $ 9.3 $ 49.8 $ — $ 59.1 Liabilities Accrued liabilities: Foreign currency forward contracts $ — $ 0.3 $ — $ 0.3 Total liabilities $ — $ 0.3 $ — $ 0.3 The carrying value of investments in non-marketable equity securities recorded to fair value on a non-recurring basis is adjusted for observable transactions for identical or similar investments of the same issuer or for impairment. These securities relate to equity investments in privately-held companies. These items measured at fair value on a non-recurring basis are classified as Level 3 in the fair value hierarchy because the value is estimated based on valuation methods using the observable transaction price at the transaction date and other unobservable inputs such as volatility, rights and obligations of the securities held. As of November 2, 2024 and February 3, 2024, non-marketable equity investments had a carrying value of $49.4 million and $45.8 million, respectively, and are included in other non-current assets in the Company’s unaudited condensed consolidated balance sheets. Fair Value Measurements at February 3, 2024 Level 1 Level 2 Level 3 Total Items measured at fair value on a recurring basis: Assets Cash equivalents: Time deposits $ — $ 2.6 $ — $ 2.6 Prepaid expenses and other current assets: Foreign currency forward contracts — 1.2 — 1.2 Other non-current assets: Marketable equity investments 9.3 — — 9.3 Severance pay fund — 0.5 — 0.5 Total assets $ 9.3 $ 4.3 $ — $ 13.6 Fair Value of Debt The Company classified the 2026 Term Loan, 2026 Senior Notes, 2028 Senior Notes, 2029 Senior Notes, 2031 Senior Notes, and 2033 Senior Notes as Level 2 in the fair value measurement hierarchy. The carrying value of the 2026 Term Loan approximates its fair value as the 2026 Term Loan is carried at a market observable interest rate that resets periodically. The estimated aggregate fair value of the unsecured senior notes was $3.4 billion at November 2, 2024 and $3.3 billion at February 3, 2024, and were classified as Level 2 as there are quoted prices from less active markets for the notes. See “Note 7 – Debt” for additional information.

Debt

Debt	9 Months Ended
Debt	Nov. 02, 2024
Debt Disclosure [Abstract]
Debt	Debt Summary of Borrowings and Outstanding Debt The following table summarizes the Company’s outstanding debt at November 2, 2024 and February 3, 2024 (in millions): November 2, February 3, Face Value Outstanding: 2026 Term Loan - 5-Year Tranche $ 623.4 $ 700.0 Term Loan Total 623.4 700.0 4.875% MTG/MTI 2028 Senior Notes 499.9 499.9 1.650% 2026 Senior Notes 500.0 500.0 2.450% 2028 Senior Notes 750.0 750.0 5.750% 2029 Senior Notes 500.0 500.0 2.950% 2031 Senior Notes 750.0 750.0 5.950% 2033 Senior Notes 500.0 500.0 Senior Notes Total 3,499.9 3,499.9 Total borrowings $ 4,123.3 $ 4,199.9 Less: Unamortized debt discount and issuance cost (28.4) (34.0) Net carrying amount of debt $ 4,094.9 $ 4,165.9 Less: Current portion (1) 129.4 107.3 Non-current portion $ 3,965.5 $ 4,058.6 (1) As of November 2, 2024, the current portion of outstanding debt that is due within twelve months includes a portion of the 2026 Term Loan - 5-Year Tranche. The weighted-average interest rate on short-term debt outstanding at November 2, 2024 and February 3, 2024 was 6.171% and 6.830%, respectively. 2024 and 2026 Term Loans On December 7, 2020, the Company entered into a term loan credit agreement with a lending syndicate led by JP Morgan Chase Bank, N.A (the “2024 and 2026 Term Loan Agreement”) in order to finance the acquisition of Inphi Corporation (“Inphi”). The 2024 and 2026 Term Loan Agreement provides for borrowings of $1.8 billion consisting of: (i) $875.0 million loan with a 3-year term from the funding date (the “3-Year Tranche Loan”) and (ii) $875.0 million loan with a 5-year term from the funding date (the “5-Year Tranche Loan” and, together with the 3-Year Tranche Loan, the “2024 and 2026 Term Loans”). On April 14, 2023, the Company entered into an amendment to the 2024 and 2026 Term Loan Agreement. The amendment modifies the existing agreement to, among other things, adopt Secured Overnight Financing Rate (“SOFR”) interest rates and conform the maximum leverage ratio financial covenant with the amended and restated revolving credit agreement. The 3-Year Tranche Loan, due on April 19, 2024, which had a remaining principal of $735.0 million, was repaid in full during the quarter ended October 28, 2023. Pursuant to the amended 2024 and 2026 Term Loan Agreement, the 5-Year Tranche Loan has a stated floating interest rate which equates to adjusted term SOFR + 137.5 bps. The effective interest rate for the 5-Year Tranche Loan was 4.980% as of November 2, 2024. The 5-Year Tranche Loan requires scheduled principal payments at the end of each fiscal quarter equal to (i) 1.25% of the aggregate principal amount on the term funding date for the first four full fiscal quarters following the term loan funding date, (ii) 2.50% of the aggregate principal amount on the term funding date for the fifth through twelfth full fiscal quarters following the term loan funding date, and (iii) 3.75% of the aggregate principal amount on the term funding date for each fiscal quarter following the twelfth full fiscal quarter following the term loan funding date. During the three and nine months ended November 2, 2024, the Company repaid $32.8 million and $76.6 million, respectively, of the principal outstanding of the 5-Year Tranche Loan. As of November 2, 2024, the Company had $623.4 million of 5-Year Tranche Loan borrowings outstanding. The 2024 and 2026 Term Loan Agreement requires that the Company and its subsidiaries comply with covenants relating to customary matters, including with respect to creating or permitting certain liens, entering into sale and leaseback transactions, and consolidating, merging, liquidating or dissolving. It also prohibits subsidiaries of the Company from incurring additional indebtedness, subject to certain exceptions, and requires that the Company maintain a leverage ratio financial covenant as of the end of any fiscal quarter. 2023 Revolving Credit Facility On December 7, 2020, the Company entered into a revolving line of credit agreement with a lending syndicate led by JP Morgan Chase Bank, N.A for borrowings of up to $750.0 million. On April 14, 2023, the Company entered into an agreement to amend and restate the credit facility to increase the borrowing capacity to $1.0 billion (as so amended and restated, the “2023 Revolving Credit Facility”). The 2023 Revolving Credit Facility has a 5-year term and a stated floating interest rate which equates to an adjusted term SOFR plus an applicable margin. The borrowings from the Revolving Loans will be used for general corporate purposes of the Company. The Company may prepay any borrowings at any time without premium or penalty. An unused commitment fee is payable quarterly based on unused balances at a rate that is based on the ratings of the Company’s senior unsecured long-term indebtedness. This annual rate was 0.175% at November 2, 2024. As of November 2, 2024, the 2023 Revolving Credit Facility was undrawn and available for draw down through April 14, 2028. The 2023 Revolving Credit Facility requires that the Company and its subsidiaries comply with covenants relating to customary matters. The covenants are consistent with the 2024 and 2026 Term Loan Agreement covenants discussed above. As of November 2, 2024, the Company was in compliance with its debt covenants for the credit agreements discussed above. 2029 and 2033 Senior Unsecured Notes On September 18, 2023, the Company completed an offering of (i) $500.0 million aggregate principal amount of the Company’s 5.750% Senior Notes due 2029 (the “2029 Senior Notes”) and (ii) $500.0 million aggregate principal amount of the Company’s 5.950% Senior Notes due 2033 (the “2033 Senior Notes”, and, together with the 2029 Senior Notes, the “2029 and 2033 Senior Notes”). The 2029 Senior Notes have a 5.5-year term and mature on February 15, 2029 and the 2033 Senior Notes have a 10-year term and mature on September 15, 2033. The stated and effective interest rates for the 2029 Senior Notes are 5.750% and 5.891%, respectively. The stated and effective interest rates for the 2033 Senior Notes are 5.950% and 6.082%, respectively. The Company may redeem the 2029 and 2033 Senior Notes, in whole or in part, at any time prior to their maturity at the redemption prices set forth in 2029 and 2033 Senior Notes. In addition, upon the occurrence of a change of control repurchase event (which involves the occurrence of both a change of control and a ratings event involving the 2029 and 2033 Senior Notes being rated below investment grade), the Company will be required to make an offer to repurchase the 2029 and 2033 Senior Notes at a price equal to 101% of the principal amount of the notes, plus accrued and unpaid interest to, but excluding, the repurchase date. The indenture governing the 2029 and 2033 Senior Notes also contains certain limited covenants restricting the Company’s ability to incur certain liens, enter into certain sale and leaseback transactions and merge or consolidate with any other entity or convey, transfer or lease all or substantially all of the Company’s properties or assets to another person, which, in each case, are subject to certain qualifications and exceptions. As of November 2, 2024, the Company had $1.0 billion borrowings outstanding from 2029 and 2033 Senior Notes. 2026, 2028, and 2031 Senior Unsecured Notes On April 12, 2021, the Company completed an offering of (i) $500.0 million aggregate principal amount of the Company’s 1.650% Senior Notes due 2026 (the “2026 Senior Notes”), (ii) $750.0 million aggregate principal amount of the Company’s 2.450% Senior Notes due 2028 (the “2028 Senior Notes”) and (iii) $750.0 million aggregate principal amount of the Company’s 2.950% Senior Notes due 2031 (the “2031 Senior Notes”, and, together with the 2026 Senior Notes and the 2028 Senior Notes, the “2026, 2028 and 2031 Senior Notes”). On October 8, 2021, the 2026, 2028 and 2031 Senior Notes issued on April 12, 2021 were exchanged for new notes. The terms of the new notes issued in the exchange are substantially identical to the notes issued in April 2021, except that the new notes are registered under the Securities Act of 1933, as amended (the “Securities Act”) and the transfer restrictions and registration rights applicable to the 2026, 2028 and 2031 Senior Notes issued in April 2021 do not apply to the new notes. The 2026 Senior Notes have a 5-year term and mature on April 15, 2026, the 2028 Senior Notes have a 7-year term and mature on April 15, 2028, and the 2031 Senior Notes have a 10-year term and mature on April 15, 2031. The stated and effective interest rates for the 2026 Senior Notes are 1.650% and 1.839%, respectively. The stated and effective interest rates for the 2028 Senior Notes are 2.450% and 2.554%, respectively. The stated and effective interest rates for the 2031 Senior Notes are 2.950% and 3.043%, respectively. The Company may redeem the 2026, 2028 and 2031 Senior Notes, in whole or in part, at any time prior to their respective maturity at the redemption prices set forth in the indenture governing the 2026, 2028 and 2031 Senior Notes. In addition, upon the occurrence of a change of control repurchase event (which involves the occurrence of both a change of control and a ratings event involving the 2026, 2028 and 2031 Senior Notes being rated below investment grade), the Company will be required to make an offer to repurchase the 2026, 2028 and 2031 Senior Notes at a price equal to 101% of the principal amount of the notes, plus accrued and unpaid interest to, but excluding, the repurchase date. The indenture governing the 2026, 2028 and 2031 Senior Notes also contains certain limited covenants restricting the Company’s ability to incur certain liens, enter into certain sale and leaseback transactions and merge or consolidate with any other entity or convey, transfer or lease all or substantially all of the Company’s properties or assets to another person, which, in each case, are subject to certain qualifications and exceptions. As of November 2, 2024, the Company had $2.0 billion borrowings outstanding from 2026, 2028 and 2031 Senior Notes. 2023 and 2028 Senior Unsecured Notes On June 22, 2018, the Company’s Bermuda-based parent company Marvell Technology Group, Ltd. (“MTG”) completed a public offering of (i) $500.0 million aggregate principal amount of 4.200% Senior Notes due 2023 (the “MTG 2023 Notes”) and (ii) $500.0 million aggregate principal amount of 4.875% Senior Notes due 2028 (the “MTG 2028 Notes” and, together with the MTG 2023 Notes, the “MTG Senior Notes”). In April 2021, in conjunction with the Company’s U.S. domiciliation, the Company commenced Exchange Offers on April 19, 2021 for the outstanding $1.0 billion in aggregate principal amount of the MTG Senior Notes outstanding in exchange for corresponding senior notes to be issued by the Company’s U.S. domiciled parent MTI. MTI made an offer to (i) exchange any and all of the outstanding MTG 2023 Notes for up to an aggregate principal amount of $500.0 million of new 4.200% Senior Notes due 2023 issued by MTI (the “MTI 2023 Notes”) and to (ii) exchange any and all of the outstanding MTG 2028 Notes for up to an aggregate principal amount of $500.0 million of new 4.875% Senior Notes due 2028 issued by MTI (the “MTI 2028 Notes” and, together with the MTI 2023 Notes, the “MTI Senior Notes”). Each new series of MTI Senior Notes have the same interest rate, maturity date, redemption terms and interest payment dates and are subject to substantially similar covenants as the corresponding series of the MTG Senior Notes for which they were offered in exchange. The settlement of the Exchange Offers occurred on May 4, 2021 with $433.9 million aggregate principal amount of the MTG 2023 Notes and $479.5 million aggregate principal amount of the MTG 2028 Notes. The exchange was accounted for as a debt modification in accordance with applicable accounting guidance. On December 16, 2021, the MTI Senior Notes issued on May 4, 2021 were exchanged for new notes. The terms of the new notes issued in the exchange are substantially identical to the notes issued in May 2021, except that the new notes are registered under the Securities Act and the transfer restrictions and registration rights applicable to the MTI Senior Notes issued in May 2021 do not apply to the new notes. The MTI 2023 Notes and MTG 2023 Notes with aggregate principal of $500.0 million matured on June 22, 2023 and was repaid. The MTI 2028 Notes mature on June 22, 2028. The stated and effective interest rates for the MTI 2028 Notes are 4.875% and 4.988%, respectively. The Company may redeem the MTI Senior Notes, in whole or in part, at any time prior to their maturity at the redemption prices set forth in MTI Senior Notes. In addition, upon the occurrence of a change of control repurchase event (which involves the occurrence of both a change of control and a ratings event involving the MTI Senior Notes being rated below investment grade), the Company will be required to make an offer to repurchase the MTI Senior Notes at a price equal to 101% of the principal amount of the notes, plus accrued and unpaid interest to, but excluding, the repurchase date. The indenture governing the MTI Senior Notes also contains certain limited covenants restricting the Company’s ability to incur certain liens, enter into certain sale and leaseback transactions and merge or consolidate with any other entity or convey, transfer or lease all or substantially all of the Company’s properties or assets to another person, which, in each case, are subject to certain qualifications and exceptions. The MTG 2028 Notes mature on June 22, 2028. The stated and effective interest rates for the MTG 2028 Notes are 4.875% and 4.940%, respectively. The Company may redeem the MTG Senior Notes, in whole or in part, at any time prior to their maturity at the redemption prices set forth in MTG Senior Notes. As of November 2, 2024, the Company had $499.9 million borrowings outstanding from MTI 2028 Notes and MTG 2028 Notes. Interest Expense and Future Contractual Maturities During the three and nine months ended November 2, 2024, the Company recognized $45.6 million and $138.9 million, respectively, of interest expense in its unaudited condensed consolidated statements of operations related to interest, amortization of debt issuance costs and accretion of discount associated with the outstanding debt. During the three and nine months ended October 28, 2023, the Company recognized $49.6 million and $152.0 million, respectively, of interest expense in its unaudited condensed consolidated statements of operations related to interest, amortization of debt issuance costs and accretion of discount associated with the outstanding debt. As of November 2, 2024, the aggregate future contractual maturities of the Company’s outstanding debt, at face value, are as follows (in millions): Fiscal Year Amount Remainder of 2025 $ 32.8 2026 131.2 2027 959.4 2028 — 2029 1,249.9 Thereafter 1,750.0 Total $ 4,123.3

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
Commitments and Contingencies	Nov. 02, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Warranty Obligations The Company generally warrants that its products sold to its customers will conform to its approved specifications and be free from defects in material and workmanship under normal use and conditions for one year. The Company may offer a longer warranty period in limited situations based on product type and negotiated warranty terms with certain customers. Commitments The Company’s commitments primarily consist of wafer purchase obligations with foundry partners, supply capacity reservation payment commitments with foundries and test & assembly partners, and technology license fee obligations. Total future unconditional purchase commitments as of November 2, 2024, are as follows (in millions): Fiscal Year Purchase Commitments to Foundries and Test & Assembly Partners Technology License Fees Remainder of 2025 $ 640.8 $ 21.9 2026 557.8 86.5 2027 131.1 56.7 2028 96.5 56.4 2029 68.4 50.6 Thereafter 248.8 118.2 Total unconditional purchase commitments $ 1,743.4 $ 390.3 Technology license fees include the liabilities under agreements for technology licenses between the Company and various vendors. Under the Company’s manufacturing relationships with its foundry partners, cancellation of outstanding purchase orders is allowed but requires payment of all costs and expenses incurred through the date of cancellation, and in some cases, may result in incremental fees, loss of amounts paid in advance, or loss of priority to reserved capacity for a period of time. The Company entered into manufacturing supply capacity reservation agreements with foundries and test & assembly suppliers in prior fiscal years. Under these arrangements, the Company agreed to pay capacity fees or refundable deposits to the suppliers in exchange for reserved manufacturing production capacity over the term of the agreements, which ranges from 4 to 10 years. In addition, the Company committed to certain purchase levels that were in line with the capacity reserved. During the first and second quarters of fiscal 2025, the Company worked with its foundry and test & assembly suppliers to amend certain manufacturing supply capacity reservation agreements, which resulted in reducing the Company’s related purchase level commitments. The Company currently estimates that it has agreed to purchase level commitments of at least $615.1 million of wafers, substrates, and other manufacturing products for the remainder of fiscal 2025 through fiscal 2033 u nder the capacity reservation agreements. In addition, total fees and refundable deposits payable under these arrangements are $59.6 million for the remainder of fiscal 2025 through fiscal 2028. Such purchase commitments are summarized in the preced ing table. In September 2021, the Company entered into a technology licensing agreement with a vendor which provides complete access to the vendor’s intellectual property portfolio for 10 years. The arrangement provides access to intellectual property over the term of the contract, including existing intellectual property, as well as intellectual property in development, and to be developed in the future. The contract provides support and maintenance over the term of the contract as well. In the third quarter of fiscal 2025, the Company ceased use of this arrangement due to restructuring actions taken during the quarter, resulting in recognition of asset impairment charges. See “Note 4 – Restructuring” for further information. Aggregate remaining fees of $268.5 million are payable quarterly over the contract term. Contingencies and Legal Proceedings The Company currently is, and may from time to time become, subject to claims, lawsuits, governmental inquiries, inspections or investigations and other legal proceedings (collectively, “Legal Matters”) arising in the course of its business. Such Legal Matters, even if not meritorious, could result in the expenditure of significant financial and managerial resources. The Company is currently unable to predict the final outcome of its pending Legal Matters and therefore cannot determine the likelihood of loss or estimate a range of possible loss, except with respect to amounts where it has determined a loss is both probable and estimable and has made an accrual. The Company evaluates, at least on a quarterly basis, developments in its Legal Matters that could affect the amount of any accrual, as well as any developments that would result in a loss contingency to become both probable and reasonably estimable. In the third quarter of fiscal 2025, the Company reserved $50.0 million in relation to a contractual disagreement with a customer that was influenced by the restructuring actions initiated by the Fiscal 2025 Plan. See “Note 4 – Restructuring” for additional information. This disagreement remains unresolved as of the third quarter ended November 2, 2024. The ultimate outcome of this and other Legal Matters involves judgments, estimates and inherent uncertainties. An unfavorable outcome in a Legal Matter could require the Company to pay damages or could prevent the Company from selling some of its products in certain jurisdictions. While the Company cannot predict with certainty the results of the Legal Matters in which it is currently involved, the Company does not expect that the ultimate costs to resolve these Legal Matters will individually or in the aggregate have a material adverse effect on its financial condition, however, there can be no assurance that the current or any future Legal Matters will be resolved in a manner that is not adverse to the Company’s business, financial statements, results of operations or cash flows. As of the end of the third quarter of fiscal 2024, the Company recognized approximately $198.0 million of charges for product related claims; such claims were fully resolved in the fourth quarter of fiscal 2024. Indemnities, Commitments and Guarantees During its normal course of business, the Company has made certain indemnities, commitments and guarantees under which it may be required to make payments in relation to certain transactions. These indemnities may include indemnities for general commercial obligations, indemnities to various lessors in connection with facility leases for certain claims arising from such facility or lease, and indemnities to directors and officers of the Company to the maximum extent permitted under the laws of Delaware. In addition, the Company has contractual commitments to various customers, which could require the Company to incur costs to repair an epidemic defect with respect to its products outside of the normal warranty period if such defect were to occur. The duration of these indemnities, commitments and guarantees varies, and in certain cases, is indefinite. Some of these indemnities, commitments and guarantees do not provide for any limitation of the maximum potential future payments that the Company could be obligated to make. In general, the Company does not record any liability for these indemnities, commitments and guarantees in the accompanying unaudited condensed consolidated balance sheets as the amounts cannot be reasonably estimated and are not considered probable. The Company does, however, accrue for losses for any known contingent liability, including those that may arise from indemnification provisions, when future payment is probable and estimable. Intellectual Property Indemnification In addition to the above indemnities, the Company has agreed to indemnify certain customers for claims made against the Company’s products where such claims allege infringement of third-party intellectual property rights, including, but not limited to, patents, registered trademarks, and/or copyrights. Under the aforementioned indemnification clauses, the Company may be obligated to defend the customer and pay for the damages awarded against the customer as well as the attorneys’ fees and costs under an infringement claim. The Company’s indemnification obligations generally do not expire after termination or expiration of the agreement containing the indemnification obligation. Generally, but not always, there are limits on and exceptions to the Company’s potential liability for indemnification. Historically the Company has not made significant payments under these indemnification obligations and the Company cannot estimate the amount of potential future payments, if any, that it might be required to make as a result of these agreements. The maximum potential amount of any future payments that the Company could be required to make under these indemnification obligations could be significant.

Income Tax

Income Tax	9 Months Ended
Income Tax	Nov. 02, 2024
Income Tax Disclosure [Abstract]
Income Tax	Income Tax The Company’s tax provision for interim periods is determined using an estimate of its annual effective tax rate, adjusted for discrete items, if any, that arise during the period. Each quarter, the Company updates its estimate of the annual effective tax rate, and if the estimated annual effective tax rate changes, the Company makes a cumulative adjustment in such period. The Company’s quarterly tax provision, and estimate of its annual effective tax rate, is subject to variation due to several factors, including variability in accurately predicting its pre-tax income or loss and the mix of jurisdictions to which they relate, intercompany transactions, changes in tax laws, the applicability of special tax regimes, changes in how the Company does business, discrete items, and acquisitions, as well as the integration of such acquisitions. The Company recorded income tax benefit of $74.2 million and $9.3 million for the three and nine months ended November 2, 2024, respectively. The Company’s estimated effective tax rate for the year differs from the U.S. statutory rate of 21% primarily due to a substantial portion of its earnings, or in some cases, losses being taxed or benefited at rates lower than the U.S. statutory rate, net of the impact of U.S. taxation of foreign operations, benefits from tax credits, valuation allowance releases as well as discrete tax benefits and expenses for excess deductions and deficiencies on stock-based compensation. The Company operates under tax incentives in certain countries that may be extended and/or renewed if certain additional requirements are satisfied. The tax incentives are conditional upon meeting certain employment and investment thresholds. No tax benefit was recorded for the three and nine months ended November 2, 2024 and October 28, 2023. The amount of unrecognized tax benefits could increase or decrease due to changes in tax law in various jurisdictions, the effects of income tax audits, and changes in the U.S. dollar as compared to foreign currencies within the next 12 months. Excluding these factors, the Company does not expect a material decrease to its uncertain tax positions as a result of the lapse of the statutes of limitations in various jurisdictions during the next 12 months.

Net Loss Per Share

Net Loss Per Share	9 Months Ended
Net Loss Per Share	Nov. 02, 2024
Earnings Per Share [Abstract]
Net Loss Per Share	Net Loss Per Share The Company reports both basic net loss per share, which is based on the weighted-average number of common stock outstanding during the period, and diluted net loss per share, which is based on the weighted-average number of common stock outstanding and potentially dilutive shares outstanding during the period. The computations of basic and diluted net loss per share are presented in the following table (in millions, except per share amounts): Three Months Ended Nine Months Ended November 2, October 28, November 2, October 28, Numerator: Net loss $ (676.3) $ (164.3) $ (1,085.2) $ (540.7) Denominator: Weighted-average shares — basic 865.7 862.6 865.5 860.1 Effect of dilutive securities: Stock-based awards — — — — Weighted-average shares — diluted 865.7 862.6 865.5 860.1 Net loss per share Basic $ (0.78) $ (0.19) $ (1.25) $ (0.63) Diluted $ (0.78) $ (0.19) $ (1.25) $ (0.63) Potential dilutive securities include dilutive common stock from stock-based awards attributable to the assumed exercise of stock options, restricted stock units and employee stock purchase plan shares using the treasury stock method. Under the treasury stock method, potential common stock outstanding are not included in the computation of diluted net income per share if their effect is anti-dilutive. Anti-dilutive potential shares are presented in the following table (in millions): Three Months Ended Nine Months Ended November 2, October 28, November 2, October 28, Weighted-average shares outstanding: Stock-based awards 11.0 11.0 11.1 8.7 Anti-dilutive potential shares from stock-based awards are excluded from the calculation of diluted earnings per share for all periods reported above because either their exercise price exceeded the average market price during the period or the stock-based awards were determined to be anti-dilutive based on applying the treasury stock method. Anti-dilutive potential shares from stock-based awards are excluded from the calculation of diluted earnings per share for the three and nine months ended November 2, 2024 and October 28, 2023 due to the net losses reported in those periods.

Supplemental Financial Informat

Supplemental Financial Information (in millions)	9 Months Ended
Supplemental Financial Information (in millions)	Nov. 02, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Supplemental Financial Information (in millions)	Supplemental Financial Information (in millions) Consolidated Balance Sheets Accounts Receivable, net The Company sells certain of its trade accounts receivable on a non-recourse basis to a third-party financial institution pursuant to a factoring arrangement. The Company accounts for these transactions as sales of receivables and presents cash proceeds as cash provided by operating activities in the unaudited condensed consolidated statements of cash flows. After the sale of its trade accounts receivable, the Company will collect payment from the customer and remit it to the third-party financial institution. Total trade accounts receivable sold under the factoring arrangement were $248.8 million and $743.2 million for the three and nine months ended November 2, 2024, respectively, of which $284.3 million remained subject to servicing by the Company as of November 2, 2024. Total trade accounts receivable sold under the factoring arrangement were $174.4 million for the three and nine months ended October 28, 2023, of which $174.4 million remained subject to servicing by the Company as of October 28, 2023. Factoring fees for the sales of receivables were recorded in interest income and other, net and were not material. November 2, February 3, Inventories: Work-in-process $ 643.9 $ 523.8 Finished goods 215.5 340.6 Inventories $ 859.4 $ 864.4 November 2, February 3, Property and equipment, net: Machinery and equipment $ 1,514.7 $ 1,376.2 Land, buildings, and leasehold improvements 302.6 312.4 Computer software 127.0 116.5 Furniture and fixtures 33.5 31.7 1,977.8 1,836.8 Less: Accumulated depreciation (1,195.9) (1,080.8) Property and equipment, net $ 781.9 $ 756.0 November 2, February 3, Other non-current assets: Prepaid ship and debits $ 385.7 $ 547.6 Prepayments on supply capacity reservation agreements 288.2 302.5 Operating right-of-use assets 213.7 203.6 Technology licenses 164.0 350.6 Non-marketable equity investments 49.4 45.8 Other 64.8 56.8 Other non-current assets $ 1,165.8 $ 1,506.9 November 2, February 3, Accrued liabilities: Variable consideration estimates (1) $ 468.3 $ 610.7 Accrued restructuring 120.8 16.1 Technology license obligations 47.7 105.7 Lease liabilities - current portion 43.2 39.4 Deferred revenue 34.5 43.2 Accrued income tax payable 33.4 17.8 Accrued interest payable 22.7 41.3 Accrued warranty expense 16.9 25.5 Accrued legal reserve 1.1 76.5 Other 36.6 56.7 Accrued liabilities $ 825.2 $ 1,032.9 (1) Substantially all of the variable consideration estimate is comprised of the ship and debit claims accrual, but also includes estimated customer returns, price discounts, price protection, rebates, and stock rotation programs. November 2, February 3, Other non-current liabilities: Non-current restructuring liabilities $ 236.9 $ 0.9 Lease liabilities - non-current 203.2 196.0 Non-current income tax payable 72.0 56.6 Deferred tax liabilities 46.3 58.7 Technology license obligations 37.0 196.5 Other 18.2 15.6 Other non-current liabilities $ 613.6 $ 524.3 Accumulated Other Comprehensive Income (Loss) The changes in accumulated other comprehensive income (loss), net of tax, by components for the comparative periods are presented in the following table (in millions): Unrealized Gain Balance at February 3, 2024 $ 1.1 Other comprehensive income (loss) before reclassifications (0.8) Amounts reclassified from accumulated other comprehensive income (loss) (0.6) Net current-period other comprehensive income (loss), net of tax (1.4) Balance at November 2, 2024 $ (0.3) Unrealized Gain Balance at January 28, 2023 $ — Other comprehensive income (loss) before reclassifications (3.6) Amounts reclassified from accumulated other comprehensive income (loss) 2.2 Net current-period other comprehensive income (loss), net of tax (1.4) Balance at October 28, 2023 $ (1.4) Stock Repurchase Program On November 17, 2016, the Company announced that its Board of Directors authorized a $1.0 billion stock repurchase plan with no fixed expiration. The stock repurchase program replaced in its entirety the prior $3.3 billion stock repurchase program. On October 16, 2018, the Company announced that its Board of Directors authorized a $700.0 million addition to the balance of its existing stock repurchase program. On March 7, 2024, the Company announced that its Board of Directors authorized a $3.0 billion addition to the balance of its existing stock repurchase program. As of November 2, 2024, $2.8 billion remained available for future stock repurchases. The Company intends to effect stock repurchases in accordance with the conditions of Rule 10b-18 under the Exchange Act, but may also make repurchases in the open market outside of Rule 10b-18 or in privately negotiated transactions. The stock repurchase program is subject to market conditions and other factors, and does not obligate the Company to repurchase any dollar amount or number of shares of its common stock and the repurchase program may be extended, modified, suspended or discontinued at any time. During the three months ended November 2, 2024, the Company repurchased 2.6 million shares of its common stock for $200.0 million. During the nine months ended November 2, 2024, the Company repurchased 7.3 million shares of its common stock for $525.0 million. During the three and nine months ended October 28, 2023, the Company repurchased 0.8 million shares of its common stock for $50.0 million pursuant to a 10b5-1 trading plan. The Company records all repurchases, as well as investment purchases and sales, based on their trade date. The repurchased shares are retired immediately after repurchases are completed. Subsequent Event - Equity Warrant Subsequent to quarter end, the Company issued a warrant to a customer to purchase an aggregate of up to 4,180,683 of the Company’s common stock at an exercise price of $87.7706 per share over a seven-year term expiring in December 2031. The warrant is eligible for vesting upon meeting certain revenue milestone conditions or time-based conditions. The Company expects to account for the transaction as an equity classified transaction and recognize the fair value of the grant as a reduction of revenue during the vesting term of the customer contract.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Millions	3 Months Ended						9 Months Ended
Pay vs Performance Disclosure - USD ($) $ in Millions	Nov. 02, 2024	Aug. 03, 2024	May 04, 2024	Oct. 28, 2023	Jul. 29, 2023	Apr. 29, 2023	Nov. 02, 2024	Oct. 28, 2023
Pay vs Performance Disclosure
Net loss	$ (676.3)	$ (193.3)	$ (215.6)	$ (164.3)	$ (207.5)	$ (168.9)	$ (1,085.2)	$ (540.7)

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended	9 Months Ended
Insider Trading Arrangements	Nov. 02, 2024 shares	Nov. 02, 2024 shares
Trading Arrangements, by Individual
Material Terms of Trading Arrangement		During the quarter ended November 2, 2024, the following trading plans were adopted or terminated by an executive officer or director of the Company: Name Title Adopted or Terminated Adoption/Termination Date Plan Start Date Plan End Date Transactions Shares (1)(2) Officers Matthew J. Murphy Chairman, President and Chief Executive Officer Terminated 10/11/2024 9/16/2024 9/12/2025 Sales 72,000 Mark Casper Chief Legal Officer Adopted 10/17/2024 1/17/2025 (3) 12/31/2025 Sales 47,901 (1) Vesting of future performance shares are estimated based on target achievement. (2) If the plan covers "net" vested shares, then the current tax rate has been applied. (3) After internal review of Mr. Casper’s two trading plans, we have determined that the new plan dated October 17, 2024 and the old plan dated January 19, 2024 will not overlap.
Non-Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Terminated	false
Matthew J. Murphy [Member]
Trading Arrangements, by Individual
Name	Matthew J. Murphy
Title	Chairman, President and Chief Executive Officer
Rule 10b5-1 Arrangement Terminated	true
Termination Date	10/11/2024
Aggregate Available	72,000	72,000
Mark Casper [Member]
Trading Arrangements, by Individual
Name	Mark Casper
Title	Chief Legal Officer
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	10/17/2024
Expiration Date	12/31/2025
Arrangement Duration	348 days
Aggregate Available	47,901	47,901

Basis of Presentation (Policies

Basis of Presentation (Policies)	9 Months Ended
Basis of Presentation (Policies)	Nov. 02, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	The unaudited condensed consolidated financial statements of Marvell Technology, Inc. (“MTI”), a Delaware corporation, and its wholly owned subsidiaries (the “Company”), as of and for the three and nine months ended November 2, 2024, have been prepared as required by the U.S. Securities and Exchange Commission (the “SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) have been condensed or omitted as permitted by the SEC.
Consolidation	These unaudited condensed consolidated financial statements and related notes should be read in conjunction with the Company’s fiscal 2024 audited financial statements included in the Company’s Annual Report on Form 10-K for the fiscal year ended February 3, 2024. In the opinion of management, the financial statements include all adjustments, including normal recurring adjustments and other adjustments, that are considered necessary for fair presentation of the Company’s financial position and results of operations. All inter-company accounts and transactions have been eliminated. Operating results for the periods presented herein are not necessarily indicative of the results that may be expected for the entire year. Certain prior period amounts have been reclassified to conform to current period presentation. These financial statements should also be read in conjunction with the Company’s critical accounting policies included in the Company’s Annual Report on Form 10-K for the fiscal year ended February 3, 2024 and those included in this Quarterly Report on Form 10-Q below. All dollar amounts in the financial statements and tables in these notes, except per share amounts, are stated in millions of U.S. dollars unless otherwise noted.
Fiscal Period	The Company’s fiscal year is the 52- or 53-week period ending on the Saturday closest to January 31. Accordingly, every fifth or sixth fiscal year will have a 53-week period. The additional week in a 53-week year is added to the fourth quarter, making such quarter consist of 14 weeks. Fiscal 2024 had a 53-week year. Fiscal 2025 is a 52-week year.
Use of Estimates	Use of Estimates The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. On an ongoing basis, the Company evaluates its estimates, including those related to revenue recognition, provisions for sales returns and allowances, inventory excess and obsolescence, goodwill and other intangible assets, restructuring, income taxes, litigation and other contingencies. Actual results could differ from these estimates and such differences could affect the results of operations reported in future periods. In the current macroeconomic environment, these estimates could require increased judgment and carry a higher degree of variability and volatility. As events continue to evolve and additional information becomes available, these estimates may change materially in future periods.
Accounting Pronouncements Not Yet Effective	Accounting Pronouncements Not Yet Effective In November 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-07, Segment Reporting (Topic 280) to improve reportable segment disclosures. The update requires disclosure of incremental segment information on an annual and interim basis. The ASU is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, and requires retrospective application to all prior periods presented in the financial statements. Early adoption is permitted. The Company is evaluating the impact that this new standard will have on the Company’s consolidated financial statements disclosures. The Company does not expect the adoption of this new standard to have a material effect on the Company’s results of operations or financial condition. In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740) to improve income tax disclosures to enhance transparency and decision usefulness of income tax disclosure. The ASU is effective for fiscal years beginning after December 15, 2024 with updates to be applied on a prospective basis with the option to apply the standard retrospectively. Early adoption is permitted. The Company is evaluating the impact that this new standard will have on the Company’s consolidated financial statements.

Revenue (Tables)

Revenue (Tables)	9 Months Ended
Revenue (Tables)	Nov. 02, 2024
Revenue from Contract with Customer [Abstract]
Schedule of Disaggregation of Revenue	The following table summarizes net revenue disaggregated by end market (in millions, except percentages): Three Months Ended Nine Months Ended November 2, % of Total October 28, % of Total November 2, % of Total October 28, % of Total Net revenue by end market: Data center $ 1,101.1 73 % $ 555.8 39 % $ 2,798.4 71 % $ 1,451.4 36 % Enterprise networking 150.9 10 % 271.1 19 % 455.0 12 % 963.4 24 % Carrier infrastructure 84.7 6 % 316.5 22 % 232.4 6 % 881.9 22 % Consumer 96.5 6 % 168.7 12 % 227.4 6 % 478.5 12 % Automotive/industrial 82.9 5 % 106.5 8 % 236.7 5 % 306.0 6 % $ 1,516.1 $ 1,418.6 $ 3,949.9 $ 4,081.2 The following table summarizes net revenue disaggregated by primary geographical market based on destination of shipment (in millions, except percentages): Three Months Ended Nine Months Ended November 2, % of Total October 28, % of Total November 2, % of Total October 28, % of Total Net revenue based on destination of shipment: China $ 658.4 43 % $ 605.3 43 % $ 1,774.8 45 % $ 1,690.3 41 % United States 256.0 17 % 217.1 15 % 675.4 17 % 607.2 15 % Singapore 46.1 3 % 73.5 5 % 299.6 8 % 256.7 6 % Taiwan 198.5 13 % 22.9 2 % 279.6 7 % 135.8 3 % Thailand 73.3 5 % 94.5 7 % 233.3 6 % 215.9 5 % Malaysia 40.3 3 % 31.6 2 % 122.7 3 % 169.5 4 % Japan 55.8 4 % 37.5 3 % 106.3 3 % 125.4 3 % Finland 32.5 2 % 158.4 11 % 74.5 2 % 353.7 9 % Other 155.2 10 % 177.8 12 % 383.7 9 % 526.7 14 % $ 1,516.1 $ 1,418.6 $ 3,949.9 $ 4,081.2 The following table summarizes net revenue disaggregated by customer type (in millions, except percentages): Three Months Ended Nine Months Ended November 2, % of Total October 28, % of Total November 2, % of Total October 28, % of Total Net revenue by customer type: Direct customers $ 895.4 59 % $ 937.6 66 % $ 2,229.2 56 % $ 2,685.7 66 % Distributors 620.7 41 % 481.0 34 % 1,720.7 44 % 1,395.5 34 % $ 1,516.1 $ 1,418.6 $ 3,949.9 $ 4,081.2

Restructuring (Tables)

Restructuring (Tables)	9 Months Ended
Restructuring (Tables)	Nov. 02, 2024
Restructuring and Related Activities [Abstract]
Schedule of Restructuring and Other Related Charges	The following table provides a summary of restructuring related charges as presented in the unaudited condensed consolidated statements of operations (in millions): Three Months Ended Nine Months Ended November 2, October 28, November 2, October 28, Restructuring related charges included in cost of goods sold $ 356.8 $ — $ 356.8 $ — Restructuring related charges included in operating expenses 358.3 3.4 366.4 105.3 Restructuring related charges included in net loss $ 715.1 $ 3.4 $ 723.2 $ 105.3 The following table presents details of the restructuring related charges as presented in the unaudited condensed consolidated statements of operations (in millions): Three Months Ended Nine Months Ended November 2, October 28, November 2, October 28, Employee severance and related costs $ 6.7 $ 3.0 $ 13.6 $ 69.1 Impairment and write-off of assets Acquired intangible assets 240.1 — 240.1 — Purchased technology licenses 159.0 — 159.0 28.6 Inventories 62.0 — 62.0 — Property and equipment 34.0 — 34.0 1.3 Other non-current assets 25.2 — 25.2 — Recognition of future contractual obligations 114.0 — 114.0 — Accrued legal reserve 50.0 — 50.0 — Other 24.1 0.4 25.3 6.3 $ 715.1 $ 3.4 $ 723.2 $ 105.3
Schedule of Restructuring Reserve by Type of Cost	The following table sets forth a reconciliation of the beginning and ending restructuring liability balances by major type of cost associated with the restructuring charges (in millions): Employee Severance and Related Costs Other Exit-Related Costs Total Balance at February 3, 2024 $ 15.5 $ 1.5 $ 17.0 Charges (1) 13.6 187.8 201.4 Net cash payments (22.3) (0.9) (23.2) Non-cash items (2) — 170.5 170.5 Balance at November 2, 2024 6.8 358.9 365.7 Less: non-current portion — 236.9 236.9 Current portion $ 6.8 $ 122.0 $ 128.8 (1) Impairment and other non-cash charges of $521.8 million recognized in the current quarter were recorded directly to the unaudited condensed consolidated statements of operations and were not included in the restructuring liability balances above. (2) Includes recognition of restructuring liabilities for future contractual obligations as a result of the cease use of related assets.

Goodwill and Acquired Intangi_2

Goodwill and Acquired Intangible Assets, Net (Tables)	9 Months Ended
Goodwill and Acquired Intangible Assets, Net (Tables)	Nov. 02, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Finite-lived Intangible Assets by Major Class	As of November 2, 2024 and February 3, 2024, net carrying amounts excluding fully amortized intangible assets were as follows (in millions, except for weighted-average remaining amortization period): November 2, 2024 Gross Carrying Amounts Accumulated Amortization and Impairment Net Carrying Amounts Weighted-Average Remaining Amortization Period (Years) Developed technologies $ 5,162.0 $ (3,296.6) $ 1,865.4 3.8 Customer contracts and related relationships 2,179.0 (1,437.4) 741.6 2.6 Trade names 50.0 (35.3) 14.7 1.5 Total acquired amortizable intangible assets $ 7,391.0 $ (4,769.3) $ 2,621.7 3.4 In-process research and development 336.0 — 336.0 n/a Total acquired intangible assets $ 7,727.0 $ (4,769.3) $ 2,957.7 February 3, 2024 Gross Carrying Amounts Accumulated Amortization Net Carrying Amounts Weighted-Average Remaining Amortization Period (Years) Developed technologies $ 4,989.0 $ (2,613.5) $ 2,375.5 3.8 Customer contracts and related relationships 2,179.0 (1,191.5) 987.5 3.3 Trade names 50.0 (27.9) 22.1 2.2 Total acquired amortizable intangible assets $ 7,218.0 $ (3,832.9) $ 3,385.1 3.6 In-process research and development 619.0 — 619.0 n/a Total acquired intangible assets $ 7,837.0 $ (3,832.9) $ 4,004.1
Schedule of Indefinite-lived Intangible Assets	As of November 2, 2024 and February 3, 2024, net carrying amounts excluding fully amortized intangible assets were as follows (in millions, except for weighted-average remaining amortization period): November 2, 2024 Gross Carrying Amounts Accumulated Amortization and Impairment Net Carrying Amounts Weighted-Average Remaining Amortization Period (Years) Developed technologies $ 5,162.0 $ (3,296.6) $ 1,865.4 3.8 Customer contracts and related relationships 2,179.0 (1,437.4) 741.6 2.6 Trade names 50.0 (35.3) 14.7 1.5 Total acquired amortizable intangible assets $ 7,391.0 $ (4,769.3) $ 2,621.7 3.4 In-process research and development 336.0 — 336.0 n/a Total acquired intangible assets $ 7,727.0 $ (4,769.3) $ 2,957.7 February 3, 2024 Gross Carrying Amounts Accumulated Amortization Net Carrying Amounts Weighted-Average Remaining Amortization Period (Years) Developed technologies $ 4,989.0 $ (2,613.5) $ 2,375.5 3.8 Customer contracts and related relationships 2,179.0 (1,191.5) 987.5 3.3 Trade names 50.0 (27.9) 22.1 2.2 Total acquired amortizable intangible assets $ 7,218.0 $ (3,832.9) $ 3,385.1 3.6 In-process research and development 619.0 — 619.0 n/a Total acquired intangible assets $ 7,837.0 $ (3,832.9) $ 4,004.1
Schedule of Finite-lived Intangible Assets, Future Amortization Expense	The following table presents the estimated future amortization expense of acquired amortizable intangible assets as of November 2, 2024 (in millions): Fiscal Year Amount Remainder of 2025 $ 247.0 2026 941.7 2027 811.3 2028 282.1 2029 129.0 Thereafter 210.6 $ 2,621.7

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
Fair Value Measurements (Tables)	Nov. 02, 2024
Fair Value Disclosures [Abstract]
Schedule of Fair Value, Assets Measured on Recurring Basis	The tables below set forth, by level, the Company’s assets and liabilities that are measured at fair value on a recurring basis. The tables do not include assets and liabilities that are measured at historical cost or any basis other than fair value (in millions): Fair Value Measurements at November 2, 2024 Level 1 Level 2 Level 3 Total Items measured at fair value on a recurring basis: Assets Cash equivalents: Time deposits $ — $ 49.3 $ — $ 49.3 Other non-current assets: Marketable equity investments 9.3 — — 9.3 Severance pay fund — 0.5 — 0.5 Total assets $ 9.3 $ 49.8 $ — $ 59.1 Liabilities Accrued liabilities: Foreign currency forward contracts $ — $ 0.3 $ — $ 0.3 Total liabilities $ — $ 0.3 $ — $ 0.3 Fair Value Measurements at February 3, 2024 Level 1 Level 2 Level 3 Total Items measured at fair value on a recurring basis: Assets Cash equivalents: Time deposits $ — $ 2.6 $ — $ 2.6 Prepaid expenses and other current assets: Foreign currency forward contracts — 1.2 — 1.2 Other non-current assets: Marketable equity investments 9.3 — — 9.3 Severance pay fund — 0.5 — 0.5 Total assets $ 9.3 $ 4.3 $ — $ 13.6

Debt (Tables)

Debt (Tables)	9 Months Ended
Debt (Tables)	Nov. 02, 2024
Debt Disclosure [Abstract]
Schedule of Outstanding Debt	The following table summarizes the Company’s outstanding debt at November 2, 2024 and February 3, 2024 (in millions): November 2, February 3, Face Value Outstanding: 2026 Term Loan - 5-Year Tranche $ 623.4 $ 700.0 Term Loan Total 623.4 700.0 4.875% MTG/MTI 2028 Senior Notes 499.9 499.9 1.650% 2026 Senior Notes 500.0 500.0 2.450% 2028 Senior Notes 750.0 750.0 5.750% 2029 Senior Notes 500.0 500.0 2.950% 2031 Senior Notes 750.0 750.0 5.950% 2033 Senior Notes 500.0 500.0 Senior Notes Total 3,499.9 3,499.9 Total borrowings $ 4,123.3 $ 4,199.9 Less: Unamortized debt discount and issuance cost (28.4) (34.0) Net carrying amount of debt $ 4,094.9 $ 4,165.9 Less: Current portion (1) 129.4 107.3 Non-current portion $ 3,965.5 $ 4,058.6 (1) As of November 2, 2024, the current portion of outstanding debt that is due within twelve months includes a portion of the 2026 Term Loan - 5-Year Tranche. The weighted-average interest rate on short-term debt outstanding at November 2, 2024 and February 3, 2024 was 6.171% and 6.830%, respectively.
Schedule of Aggregate Future Contractual Maturities of Debt	As of November 2, 2024, the aggregate future contractual maturities of the Company’s outstanding debt, at face value, are as follows (in millions): Fiscal Year Amount Remainder of 2025 $ 32.8 2026 131.2 2027 959.4 2028 — 2029 1,249.9 Thereafter 1,750.0 Total $ 4,123.3

Commitments and Contingencies (

Commitments and Contingencies (Tables)	9 Months Ended
Commitments and Contingencies (Tables)	Nov. 02, 2024
Commitments and Contingencies Disclosure [Abstract]
Schedule of Contractual Obligation, Fiscal Year Maturity	Total future unconditional purchase commitments as of November 2, 2024, are as follows (in millions): Fiscal Year Purchase Commitments to Foundries and Test & Assembly Partners Technology License Fees Remainder of 2025 $ 640.8 $ 21.9 2026 557.8 86.5 2027 131.1 56.7 2028 96.5 56.4 2029 68.4 50.6 Thereafter 248.8 118.2 Total unconditional purchase commitments $ 1,743.4 $ 390.3

Net Loss Per Share (Tables)

Net Loss Per Share (Tables)	9 Months Ended
Net Loss Per Share (Tables)	Nov. 02, 2024
Earnings Per Share [Abstract]
Schedule of Computation of Basic and Diluted Net Loss Per Share	The computations of basic and diluted net loss per share are presented in the following table (in millions, except per share amounts): Three Months Ended Nine Months Ended November 2, October 28, November 2, October 28, Numerator: Net loss $ (676.3) $ (164.3) $ (1,085.2) $ (540.7) Denominator: Weighted-average shares — basic 865.7 862.6 865.5 860.1 Effect of dilutive securities: Stock-based awards — — — — Weighted-average shares — diluted 865.7 862.6 865.5 860.1 Net loss per share Basic $ (0.78) $ (0.19) $ (1.25) $ (0.63) Diluted $ (0.78) $ (0.19) $ (1.25) $ (0.63)
Schedule of Anti-dilutive Potential Shares	Anti-dilutive potential shares are presented in the following table (in millions): Three Months Ended Nine Months Ended November 2, October 28, November 2, October 28, Weighted-average shares outstanding: Stock-based awards 11.0 11.0 11.1 8.7

Supplemental Financial Inform_2

Supplemental Financial Information (in millions) (Tables)	9 Months Ended
Supplemental Financial Information (in millions) (Tables)	Nov. 02, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Inventories	November 2, February 3, Inventories: Work-in-process $ 643.9 $ 523.8 Finished goods 215.5 340.6 Inventories $ 859.4 $ 864.4
Schedule of Property and Equipment, Net	November 2, February 3, Property and equipment, net: Machinery and equipment $ 1,514.7 $ 1,376.2 Land, buildings, and leasehold improvements 302.6 312.4 Computer software 127.0 116.5 Furniture and fixtures 33.5 31.7 1,977.8 1,836.8 Less: Accumulated depreciation (1,195.9) (1,080.8) Property and equipment, net $ 781.9 $ 756.0
Schedule of Other Non-current Assets	November 2, February 3, Other non-current assets: Prepaid ship and debits $ 385.7 $ 547.6 Prepayments on supply capacity reservation agreements 288.2 302.5 Operating right-of-use assets 213.7 203.6 Technology licenses 164.0 350.6 Non-marketable equity investments 49.4 45.8 Other 64.8 56.8 Other non-current assets $ 1,165.8 $ 1,506.9
Schedule of Current Accrued Liabilities	November 2, February 3, Accrued liabilities: Variable consideration estimates (1) $ 468.3 $ 610.7 Accrued restructuring 120.8 16.1 Technology license obligations 47.7 105.7 Lease liabilities - current portion 43.2 39.4 Deferred revenue 34.5 43.2 Accrued income tax payable 33.4 17.8 Accrued interest payable 22.7 41.3 Accrued warranty expense 16.9 25.5 Accrued legal reserve 1.1 76.5 Other 36.6 56.7 Accrued liabilities $ 825.2 $ 1,032.9 (1) Substantially all of the variable consideration estimate is comprised of the ship and debit claims accrual, but also includes estimated customer returns, price discounts, price protection, rebates, and stock rotation programs.
Schedule of Other Non-current Liabilities	November 2, February 3, Other non-current liabilities: Non-current restructuring liabilities $ 236.9 $ 0.9 Lease liabilities - non-current 203.2 196.0 Non-current income tax payable 72.0 56.6 Deferred tax liabilities 46.3 58.7 Technology license obligations 37.0 196.5 Other 18.2 15.6 Other non-current liabilities $ 613.6 $ 524.3
Schedule of Changes in Accumulated Other Comprehensive Income (Loss) by Components	The changes in accumulated other comprehensive income (loss), net of tax, by components for the comparative periods are presented in the following table (in millions): Unrealized Gain Balance at February 3, 2024 $ 1.1 Other comprehensive income (loss) before reclassifications (0.8) Amounts reclassified from accumulated other comprehensive income (loss) (0.6) Net current-period other comprehensive income (loss), net of tax (1.4) Balance at November 2, 2024 $ (0.3) Unrealized Gain Balance at January 28, 2023 $ — Other comprehensive income (loss) before reclassifications (3.6) Amounts reclassified from accumulated other comprehensive income (loss) 2.2 Net current-period other comprehensive income (loss), net of tax (1.4) Balance at October 28, 2023 $ (1.4)

Revenue - Net Revenue by End Ma

Revenue - Net Revenue by End Market (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Nov. 02, 2024	Oct. 28, 2023	Nov. 02, 2024	Oct. 28, 2023
Disaggregation of Revenue [Line Items]
Net revenue	$ 1,516.1	$ 1,418.6	$ 3,949.9	$ 4,081.2
Data center
Disaggregation of Revenue [Line Items]
Net revenue	$ 1,101.1	$ 555.8	$ 2,798.4	$ 1,451.4
Data center \| Net Revenue \| Product Concentration Risk
Disaggregation of Revenue [Line Items]
% of Total	73%	39%	71%	36%
Enterprise networking
Disaggregation of Revenue [Line Items]
Net revenue	$ 150.9	$ 271.1	$ 455	$ 963.4
Enterprise networking \| Net Revenue \| Product Concentration Risk
Disaggregation of Revenue [Line Items]
% of Total	10%	19%	12%	24%
Carrier infrastructure
Disaggregation of Revenue [Line Items]
Net revenue	$ 84.7	$ 316.5	$ 232.4	$ 881.9
Carrier infrastructure \| Net Revenue \| Product Concentration Risk
Disaggregation of Revenue [Line Items]
% of Total	6%	22%	6%	22%
Consumer
Disaggregation of Revenue [Line Items]
Net revenue	$ 96.5	$ 168.7	$ 227.4	$ 478.5
Consumer \| Net Revenue \| Product Concentration Risk
Disaggregation of Revenue [Line Items]
% of Total	6%	12%	6%	12%
Automotive/industrial
Disaggregation of Revenue [Line Items]
Net revenue	$ 82.9	$ 106.5	$ 236.7	$ 306
Automotive/industrial \| Net Revenue \| Product Concentration Risk
Disaggregation of Revenue [Line Items]
% of Total	5%	8%	5%	6%

Revenue - Net Revenue Based on

Revenue - Net Revenue Based on Destination of Shipment (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Nov. 02, 2024	Oct. 28, 2023	Nov. 02, 2024	Oct. 28, 2023
Disaggregation of Revenue [Line Items]
Net revenue	$ 1,516.1	$ 1,418.6	$ 3,949.9	$ 4,081.2
China
Disaggregation of Revenue [Line Items]
Net revenue	$ 658.4	$ 605.3	$ 1,774.8	$ 1,690.3
China \| Net Revenue \| Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
% of Total	43%	43%	45%	41%
United States
Disaggregation of Revenue [Line Items]
Net revenue	$ 256	$ 217.1	$ 675.4	$ 607.2
United States \| Net Revenue \| Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
% of Total	17%	15%	17%	15%
Singapore
Disaggregation of Revenue [Line Items]
Net revenue	$ 46.1	$ 73.5	$ 299.6	$ 256.7
Singapore \| Net Revenue \| Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
% of Total	3%	5%	8%	6%
Taiwan
Disaggregation of Revenue [Line Items]
Net revenue	$ 198.5	$ 22.9	$ 279.6	$ 135.8
Taiwan \| Net Revenue \| Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
% of Total	13%	2%	7%	3%
Thailand
Disaggregation of Revenue [Line Items]
Net revenue	$ 73.3	$ 94.5	$ 233.3	$ 215.9
Thailand \| Net Revenue \| Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
% of Total	5%	7%	6%	5%
Malaysia
Disaggregation of Revenue [Line Items]
Net revenue	$ 40.3	$ 31.6	$ 122.7	$ 169.5
Malaysia \| Net Revenue \| Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
% of Total	3%	2%	3%	4%
Japan
Disaggregation of Revenue [Line Items]
Net revenue	$ 55.8	$ 37.5	$ 106.3	$ 125.4
Japan \| Net Revenue \| Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
% of Total	4%	3%	3%	3%
Finland
Disaggregation of Revenue [Line Items]
Net revenue	$ 32.5	$ 158.4	$ 74.5	$ 353.7
Finland \| Net Revenue \| Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
% of Total	2%	11%	2%	9%
Other
Disaggregation of Revenue [Line Items]
Net revenue	$ 155.2	$ 177.8	$ 383.7	$ 526.7
Other \| Net Revenue \| Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
% of Total	10%	12%	9%	14%

Revenue - Net Revenue by Custom

Revenue - Net Revenue by Customer Type (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Nov. 02, 2024	Oct. 28, 2023	Nov. 02, 2024	Oct. 28, 2023
Disaggregation of Revenue [Line Items]
Net revenue	$ 1,516.1	$ 1,418.6	$ 3,949.9	$ 4,081.2
Direct customers
Disaggregation of Revenue [Line Items]
Net revenue	$ 895.4	$ 937.6	$ 2,229.2	$ 2,685.7
Direct customers \| Net Revenue \| Customer Concentration Risk
Disaggregation of Revenue [Line Items]
% of Total	59%	66%	56%	66%
Distributors
Disaggregation of Revenue [Line Items]
Net revenue	$ 620.7	$ 481	$ 1,720.7	$ 1,395.5
Distributors \| Net Revenue \| Customer Concentration Risk
Disaggregation of Revenue [Line Items]
% of Total	41%	34%	44%	34%

Restructuring - Narrative (Deta

Restructuring - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
Restructuring - Narrative (Details) - USD ($) $ in Millions	Nov. 02, 2024	Oct. 28, 2023	Nov. 02, 2024	Oct. 28, 2023
Restructuring Cost and Reserve [Line Items]
Restructuring and other related charges	$ 715.1	$ 3.4	$ 723.2	$ 105.3
Restructuring related charges			201.4
Current portion of restructuring liability	128.8		128.8
Accrued Liabilities
Restructuring Cost and Reserve [Line Items]
Current portion of restructuring liability	120.8		120.8
Accounts Payable
Restructuring Cost and Reserve [Line Items]
Current portion of restructuring liability	8		8
Contract Termination
Restructuring Cost and Reserve [Line Items]
Restructuring related charges	114	0	114	0
Fiscal 2025 Plan
Restructuring Cost and Reserve [Line Items]
Restructuring and other related charges	715.1		715.1
Fiscal 2025 Plan \| Contract Termination
Restructuring Cost and Reserve [Line Items]
Restructuring related charges	97.8		97.8
Fiscal 2025 Plan \| Intellectual Property
Restructuring Cost and Reserve [Line Items]
Impairment of intangible assets	$ 159		159
Fiscal 2024 Plan
Restructuring Cost and Reserve [Line Items]
Restructuring and other related charges		$ 3.4	$ 8.1	$ 105.3

Restructuring - Schedule of Res

Restructuring - Schedule of Restructuring Related Charges (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Nov. 02, 2024	Oct. 28, 2023	Nov. 02, 2024	Oct. 28, 2023
Restructuring Cost and Reserve [Line Items]
Restructuring related charges	$ 715.1	$ 3.4	$ 723.2	$ 105.3
Cost of goods sold
Restructuring Cost and Reserve [Line Items]
Restructuring related charges	356.8	0	356.8	0
Operating Expense
Restructuring Cost and Reserve [Line Items]
Restructuring related charges	$ 358.3	$ 3.4	$ 366.4	$ 105.3

Restructuring - Statements of O

Restructuring - Statements of Operations (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Nov. 02, 2024	Oct. 28, 2023	Nov. 02, 2024	Oct. 28, 2023
Restructuring Cost and Reserve [Line Items]
Employee severance and related costs	$ 6.7	$ 3	$ 13.6	$ 69.1
Restructuring related charges			201.4
Accrued legal reserve	50	0	50	0
Other	24.1	0.4	25.3	6.3
Restructuring related charges	715.1	3.4	723.2	105.3
Contract Termination
Restructuring Cost and Reserve [Line Items]
Restructuring related charges	114	0	114	0
Acquired intangible assets
Restructuring Cost and Reserve [Line Items]
Impairment and write-off of assets	240.1	0	240.1	0
Intellectual Property
Restructuring Cost and Reserve [Line Items]
Impairment and write-off of assets	159	0	159	28.6
Inventories
Restructuring Cost and Reserve [Line Items]
Impairment and write-off of assets	62	0	62	0
Property and equipment
Restructuring Cost and Reserve [Line Items]
Impairment and write-off of assets	34	0	34	1.3
Other non-current assets
Restructuring Cost and Reserve [Line Items]
Impairment and write-off of assets	$ 25.2	$ 0	$ 25.2	$ 0

Restructuring - Restructuring L

Restructuring - Restructuring Liability Balances by Type (Details) - USD ($) $ in Millions	3 Months Ended	9 Months Ended
	Nov. 02, 2024	Nov. 02, 2024	Feb. 03, 2024
Restructuring Reserve [Roll Forward]
Beginning balance		$ 17
Charges		201.4
Net cash payments		(23.2)
Non-cash items		170.5
Ending balance	$ 365.7	365.7
Less: non-current portion	236.9	236.9	$ 0.9
Current portion	128.8	128.8
Impairment and other non-cash charges	521.8
Employee Severance and Related Costs
Restructuring Reserve [Roll Forward]
Beginning balance		15.5
Charges		13.6
Net cash payments		(22.3)
Non-cash items		0
Ending balance	6.8	6.8
Less: non-current portion	0	0
Current portion	6.8	6.8
Other Exit-Related Costs
Restructuring Reserve [Roll Forward]
Beginning balance		1.5
Charges		187.8
Net cash payments		(0.9)
Non-cash items		170.5
Ending balance	358.9	358.9
Less: non-current portion	236.9	236.9
Current portion	$ 122	$ 122

Goodwill and Acquired Intangi_3

Goodwill and Acquired Intangible Assets, Net - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended		12 Months Ended
	Nov. 02, 2024	Oct. 28, 2023	Nov. 02, 2024	Oct. 28, 2023	Feb. 03, 2024
Finite-Lived Intangible Assets [Line Items]
Goodwill	$ 11,586.9		$ 11,586.9		$ 11,586.9
Weighted average remaining amortization period (years)			3 years 4 months 24 days		3 years 7 months 6 days
Amortization of intangible assets	264.9	$ 269.8	$ 805.5	$ 811.6
Developed technologies
Finite-Lived Intangible Assets [Line Items]
Impairment of intangible assets, finite-lived	$ 240.1
Weighted average remaining amortization period (years)			3 years 9 months 18 days		3 years 9 months 18 days
In-process research and development \| Minimum
Finite-Lived Intangible Assets [Line Items]
Weighted average remaining amortization period (years)			8 years
In-process research and development \| Maximum
Finite-Lived Intangible Assets [Line Items]
Weighted average remaining amortization period (years)			10 years

Goodwill and Acquired Intangi_4

Goodwill and Acquired Intangible Assets, Net - Net Carrying Amounts and Weighted Average Amortization Period (Details) - USD ($) $ in Millions	9 Months Ended	12 Months Ended
	Nov. 02, 2024	Feb. 03, 2024
Acquired Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amounts	$ 7,391	$ 7,218
Accumulated Amortization and Impairment	(4,769.3)	(3,832.9)
Net Carrying Amounts	2,621.7	3,385.1
Gross Carrying Amounts, Total acquired intangible assets	7,727	7,837
Net Carrying Amounts, Total acquired intangible assets	$ 2,957.7	$ 4,004.1
Weighted-Average Remaining Amortization Period (Years)	3 years 4 months 24 days	3 years 7 months 6 days
In-process research and development
Acquired Finite-Lived Intangible Assets [Line Items]
In-process research and development	$ 336	$ 619
Developed technologies
Acquired Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amounts	5,162	4,989
Accumulated Amortization and Impairment	(3,296.6)	(2,613.5)
Net Carrying Amounts	$ 1,865.4	$ 2,375.5
Weighted-Average Remaining Amortization Period (Years)	3 years 9 months 18 days	3 years 9 months 18 days
Customer contracts and related relationships
Acquired Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amounts	$ 2,179	$ 2,179
Accumulated Amortization and Impairment	(1,437.4)	(1,191.5)
Net Carrying Amounts	$ 741.6	$ 987.5
Weighted-Average Remaining Amortization Period (Years)	2 years 7 months 6 days	3 years 3 months 18 days
Trade names
Acquired Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amounts	$ 50	$ 50
Accumulated Amortization and Impairment	(35.3)	(27.9)
Net Carrying Amounts	$ 14.7	$ 22.1
Weighted-Average Remaining Amortization Period (Years)	1 year 6 months	2 years 2 months 12 days

Goodwill and Acquired Intangi_5

Goodwill and Acquired Intangible Assets, Net - Future Amortization (Details) - USD ($) $ in Millions	Nov. 02, 2024	Feb. 03, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Remainder of 2025	$ 247
2026	941.7
2027	811.3
2028	282.1
2029	129
Thereafter	210.6
Net Carrying Amounts	$ 2,621.7	$ 3,385.1

Fair Value Measurements - Fair

Fair Value Measurements - Fair Value, Assets (Details) - USD ($) $ in Millions	Nov. 02, 2024	Feb. 03, 2024
Assets
Foreign currency forward contracts		$ 1.2
Marketable equity investments	$ 9.3	9.3
Severance pay fund	0.5	0.5
Total assets	59.1	13.6
Liabilities
Total liabilities	0.3
Foreign currency forward contracts
Liabilities
Foreign currency forward contracts	0.3
Level 1
Assets
Foreign currency forward contracts		0
Marketable equity investments	9.3	9.3
Severance pay fund	0	0
Total assets	9.3	9.3
Liabilities
Total liabilities	0
Level 1 \| Foreign currency forward contracts
Liabilities
Foreign currency forward contracts	0
Level 2
Assets
Foreign currency forward contracts		1.2
Marketable equity investments	0	0
Severance pay fund	0.5	0.5
Total assets	49.8	4.3
Liabilities
Total liabilities	0.3
Level 2 \| Foreign currency forward contracts
Liabilities
Foreign currency forward contracts	0.3
Level 3
Assets
Foreign currency forward contracts		0
Marketable equity investments	0	0
Severance pay fund	0	0
Total assets	0	0
Liabilities
Total liabilities	0
Level 3 \| Foreign currency forward contracts
Liabilities
Foreign currency forward contracts	0
Time deposits
Assets
Time deposits	49.3	2.6
Time deposits \| Level 1
Assets
Time deposits	0	0
Time deposits \| Level 2
Assets
Time deposits	49.3	2.6
Time deposits \| Level 3
Assets
Time deposits	$ 0	$ 0

Fair Value Measurements - Narra

Fair Value Measurements - Narrative (Details) - USD ($) $ in Millions	Nov. 02, 2024	Feb. 03, 2024
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Non-marketable equity investments	$ 49.4	$ 45.8
Level 2 \| Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Long term convertible debt	$ 3,400	$ 3,300

Debt - Schedule of Outstanding

Debt - Schedule of Outstanding Debt (Details) - USD ($) $ in Millions				9 Months Ended
	Sep. 18, 2023	Apr. 12, 2021	Dec. 07, 2020	Nov. 02, 2024	Feb. 03, 2024
Debt Instrument [Line Items]
Total borrowings				$ 4,123.3	$ 4,199.9
Less: Unamortized debt discount and issuance cost				(28.4)	(34)
Net carrying amount of debt				4,094.9	4,165.9
Non-current portion				$ 3,965.5	$ 4,058.6
Weighted-average interest rate				6.171%	6.83%
Term Loan
Debt Instrument [Line Items]
Total borrowings				$ 623.4	$ 700
Less: Current portion				129.4	107.3
Term Loan \| 2026 Term Loan - 5-Year Tranche
Debt Instrument [Line Items]
Total borrowings				$ 623.4	700
Debt term (in years)			5 years	5 years
Senior Notes
Debt Instrument [Line Items]
Total borrowings				$ 3,499.9	3,499.9
Net carrying amount of debt				$ 2,000
Senior Notes \| 4.875% MTG/MTI 2028 Senior Notes
Debt Instrument [Line Items]
Stated interest rate (as a percent)				4.875%
Total borrowings				$ 499.9	499.9
Senior Notes \| 1.650% 2026 Senior Notes
Debt Instrument [Line Items]
Stated interest rate (as a percent)		1.65%		1.65%
Total borrowings				$ 500	500
Debt term (in years)		5 years
Senior Notes \| 2.450% 2028 Senior Notes
Debt Instrument [Line Items]
Stated interest rate (as a percent)		2.45%		2.45%
Total borrowings				$ 750	750
Debt term (in years)		7 years
Senior Notes \| 5.750% 2029 Senior Notes
Debt Instrument [Line Items]
Stated interest rate (as a percent)	5.75%			5.75%
Total borrowings				$ 500	500
Debt term (in years)	5 years 6 months
Senior Notes \| 2.950% 2031 Senior Notes
Debt Instrument [Line Items]
Stated interest rate (as a percent)		2.95%		2.95%
Total borrowings				$ 750	750
Debt term (in years)		10 years
Senior Notes \| 5.950% 2033 Senior Notes
Debt Instrument [Line Items]
Stated interest rate (as a percent)	5.95%			5.95%
Total borrowings				$ 500	$ 500
Debt term (in years)	10 years

Debt - Term Loans (Details)

Debt - Term Loans (Details) - USD ($)		3 Months Ended		9 Months Ended
Debt - Term Loans (Details) - USD ($)	Dec. 07, 2020	Nov. 02, 2024	Oct. 28, 2023	Nov. 02, 2024	Feb. 03, 2024
Debt Instrument [Line Items]
Total borrowings		$ 4,123,300,000		$ 4,123,300,000	$ 4,199,900,000
Term Loan
Debt Instrument [Line Items]
Borrowing capacity	$ 1,800,000,000
Total borrowings		623,400,000		$ 623,400,000	700,000,000
Term Loan \| 3-Year Tranche Loan
Debt Instrument [Line Items]
Borrowing capacity	$ 875,000,000
Debt term (in years)	3 years		3 years
Repayments of debt			$ 735,000,000
Term Loan \| 5-Year Tranche Loan
Debt Instrument [Line Items]
Borrowing capacity	$ 875,000,000
Debt term (in years)	5 years			5 years
Repayments of debt		$ 32,800,000		$ 76,600,000
Basis spread on variable rate (as a percent)				1.375%
Effective interest rate (as a percent)		4.98%		4.98%
Total borrowings		$ 623,400,000		$ 623,400,000	$ 700,000,000
Term Loan \| 5-Year Tranche Loan \| Debt Instrument, Redemption, Period One
Debt Instrument [Line Items]
Percentage of principal				1.25%
Term Loan \| 5-Year Tranche Loan \| Debt Instrument, Redemption, Period Two
Debt Instrument [Line Items]
Percentage of principal				2.50%
Term Loan \| 5-Year Tranche Loan \| Debt Instrument, Redemption, Period Three
Debt Instrument [Line Items]
Percentage of principal				3.75%

Debt - Revolving Credit Facilit

Debt - Revolving Credit Facility (Details) - Revolving Credit Facility - Line of Credit - USD ($) $ in Millions		9 Months Ended
	Apr. 14, 2023	Nov. 02, 2024	Dec. 07, 2020
2020 Revolving Credit Facility
Line of Credit Facility [Line Items]
Borrowing capacity			$ 750
2023 Revolving Credit Facility
Line of Credit Facility [Line Items]
Borrowing capacity	$ 1,000
Debt term (in years)	5 years
Unused commitment fee percentage		0.175%

Debt - Senior Unsecured Notes (

Debt - Senior Unsecured Notes (Details) - USD ($) $ in Millions					1 Months Ended
	Sep. 18, 2023	Jun. 22, 2023	May 04, 2021	Apr. 12, 2021	Apr. 30, 2021	Nov. 02, 2024	Feb. 03, 2024	Jun. 22, 2018
Debt Instrument [Line Items]
Long-term debt						$ 4,094.9	$ 4,165.9
Notes
Debt Instrument [Line Items]
Redemption price percentage				101%
Long-term debt						$ 2,000
5.750% 2029 Senior Notes \| Notes
Debt Instrument [Line Items]
Aggregate principal amount	$ 500
Stated interest rate (as a percent)	5.75%					5.75%
Debt term (in years)	5 years 6 months
Effective interest rate (as a percent)	5.891%
5.950% 2033 Senior Notes \| Notes
Debt Instrument [Line Items]
Aggregate principal amount	$ 500
Stated interest rate (as a percent)	5.95%					5.95%
Debt term (in years)	10 years
Effective interest rate (as a percent)	6.082%
Senior Notes Due 2029 and 2033 \| Notes
Debt Instrument [Line Items]
Redemption price percentage	101%
Long-term debt						$ 1,000
Senior Notes Due 2026 \| Notes
Debt Instrument [Line Items]
Aggregate principal amount				$ 500
Stated interest rate (as a percent)				1.65%		1.65%
Debt term (in years)				5 years
Effective interest rate (as a percent)				1.839%
Senior Notes Due 2028 \| Notes
Debt Instrument [Line Items]
Aggregate principal amount				$ 750
Stated interest rate (as a percent)				2.45%		2.45%
Debt term (in years)				7 years
Effective interest rate (as a percent)				2.554%
Senior Notes Due 2031 \| Notes
Debt Instrument [Line Items]
Aggregate principal amount				$ 750
Stated interest rate (as a percent)				2.95%		2.95%
Debt term (in years)				10 years
Effective interest rate (as a percent)				3.043%
MTG Senior Notes Due 2023 \| Notes
Debt Instrument [Line Items]
Aggregate principal amount								$ 500
Stated interest rate (as a percent)								4.20%
Principal amount exchanged			$ 433.9
MTG Senior Notes Due 2028 \| Notes
Debt Instrument [Line Items]
Aggregate principal amount					$ 500			$ 500
Stated interest rate (as a percent)					4.875%			4.875%
Effective interest rate (as a percent)					4.94%
Principal amount exchanged			$ 479.5
MTG Senior Notes \| Notes
Debt Instrument [Line Items]
Long-term debt					$ 1,000
MTI Senior Notes Due 2023 \| Notes
Debt Instrument [Line Items]
Aggregate principal amount					$ 500
Stated interest rate (as a percent)					4.20%
MTI and MTG 2023 Notes \| Notes
Debt Instrument [Line Items]
Repayments of senior notes		$ 500
MTI Senior Notes Due 2028 \| Notes
Debt Instrument [Line Items]
Stated interest rate (as a percent)					4.875%
Effective interest rate (as a percent)					4.988%
MTI Senior Notes \| Notes
Debt Instrument [Line Items]
Redemption price percentage					101%
MTG and MTI 2028 Senior Notes \| Notes
Debt Instrument [Line Items]
Long-term debt						$ 499.9

Debt - Interest Expense and Fut

Debt - Interest Expense and Future Contractual Maturities (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Nov. 02, 2024	Oct. 28, 2023	Nov. 02, 2024	Oct. 28, 2023
Debt Disclosure [Abstract]
Interest expense	$ 45.6	$ 49.6	$ 138.9	$ 152

Debt - Future Maturities (Detai

Debt - Future Maturities (Details) - USD ($) $ in Millions	Nov. 02, 2024	Feb. 03, 2024
Fiscal Year
Remainder of 2025	$ 32.8
2026	131.2
2027	959.4
2028	0
2029	1,249.9
Thereafter	1,750
Total	$ 4,123.3	$ 4,199.9

Commitments and Contingencies -

Commitments and Contingencies - Narrative (Details) - USD ($) $ in Millions	1 Months Ended	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Nov. 02, 2024	Oct. 28, 2023	Nov. 02, 2024	Oct. 28, 2023
Long-term Purchase Commitment [Line Items]
Standard warranty period				1 year
Loss contingency accrual, period increase		$ 50	$ 0	$ 50	$ 0
Charges for product related claims			$ 198
Wafers, Substrates, and Other Manufacturing Products
Long-term Purchase Commitment [Line Items]
Estimated commitment				615.1
Fees payable		59.6		59.6
Technology License Fees
Long-term Purchase Commitment [Line Items]
Purchase commitment period	10 years
Fees payable		$ 268.5		$ 268.5
Minimum \| Wafers, Substrates, and Other Manufacturing Products
Long-term Purchase Commitment [Line Items]
Purchase commitment period				4 years
Maximum \| Wafers, Substrates, and Other Manufacturing Products
Long-term Purchase Commitment [Line Items]
Purchase commitment period				10 years

Commitments and Contingencies_2

Commitments and Contingencies - Future Minimum Payments Under Technology License Obligations (Details) $ in Millions	Nov. 02, 2024 USD ($)
Purchase Commitments to Foundries and Test & Assembly Partners
Fiscal Year
Remainder of 2025	$ 640.8
2026	557.8
2027	131.1
2028	96.5
2029	68.4
Thereafter	248.8
Total unconditional purchase commitments	1,743.4
Technology License Fees
Fiscal Year
Remainder of 2025	21.9
2026	86.5
2027	56.7
2028	56.4
2029	50.6
Thereafter	118.2
Total unconditional purchase commitments	$ 390.3

Income Tax (Details)

Income Tax (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended		9 Months Ended
	Nov. 02, 2024	Oct. 28, 2023	Nov. 02, 2024	Oct. 28, 2023
Income Tax Disclosure [Abstract]
Income tax benefit	$ (74.2)	$ (23.2)	$ (9.3)	$ (130.7)
Benefit of tax incentives on earnings per share (in dollars per share)	$ 0	$ 0	$ 0	$ 0

Net Loss Per Share - Computatio

Net Loss Per Share - Computation of Basic and Diluted Net Loss Per Share (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended						9 Months Ended
	Nov. 02, 2024	Aug. 03, 2024	May 04, 2024	Oct. 28, 2023	Jul. 29, 2023	Apr. 29, 2023	Nov. 02, 2024	Oct. 28, 2023
Numerator:
Net loss	$ (676.3)	$ (193.3)	$ (215.6)	$ (164.3)	$ (207.5)	$ (168.9)	$ (1,085.2)	$ (540.7)
Denominator:
Weighted-average shares — basic (in shares)	865.7			862.6			865.5	860.1
Effect of dilutive securities:
Stock-based awards (in shares)	0			0			0	0
Weighted-average shares — diluted (in shares)	865.7			862.6			865.5	860.1
Net loss per share
Basic (in dollars per share)	$ (0.78)			$ (0.19)			$ (1.25)	$ (0.63)
Diluted (in dollars per share)	$ (0.78)			$ (0.19)			$ (1.25)	$ (0.63)

Net Loss Per Share - Anti-dilut

Net Loss Per Share - Anti-dilutive Potential Shares (Details) - shares shares in Millions	3 Months Ended		9 Months Ended
	Nov. 02, 2024	Oct. 28, 2023	Nov. 02, 2024	Oct. 28, 2023
Stock-based awards
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Weighted-average shares outstanding (in shares)	11	11	11.1	8.7

Supplemental Financial Inform_3

Supplemental Financial Information (in millions) - Narrative (Details) - USD ($)	1 Months Ended	3 Months Ended				9 Months Ended
	Dec. 04, 2024	Nov. 02, 2024	Aug. 03, 2024	May 04, 2024	Oct. 28, 2023	Nov. 02, 2024	Oct. 28, 2023	Mar. 07, 2024	Oct. 16, 2018	Nov. 17, 2016	Nov. 16, 2016
Subsequent Event [Line Items]
Trade accounts receivable sold, total		$ 248,800,000			$ 174,400,000	$ 743,200,000	$ 174,400,000
Trade accounts receivable sold, subject to servicing		284,300,000			$ 174,400,000	284,300,000	$ 174,400,000
Authorized repurchase amount										$ 1,000,000,000	$ 3,300,000,000
Stock repurchase program, additional authorized amount								$ 3,000,000,000	$ 700,000,000
Remaining available for future share repurchases (in shares)		$ 2,800,000,000				$ 2,800,000,000
Repurchase of common stock (in shares)		2,600,000			800,000	7,300,000	800,000
Repurchase of common stock, value		$ 200,000,000	$ 175,000,000	$ 150,000,000	$ 50,000,000	$ 525,000,000	$ 50,000,000
Subsequent Event
Subsequent Event [Line Items]
Number of securities called by warrants (in shares)	4,180,683
Exercise price (in dollars per share)	$ 87.7706
Warrant term	7 years

Supplemental Financial Inform_4

Supplemental Financial Information (in millions) - Inventories (Details) - USD ($) $ in Millions	Nov. 02, 2024	Feb. 03, 2024
Inventories:
Work-in-process	$ 643.9	$ 523.8
Finished goods	215.5	340.6
Inventories	$ 859.4	$ 864.4

Supplemental Financial Inform_5

Supplemental Financial Information (in millions) - Property and Equipment, Net (Details) - USD ($) $ in Millions	Nov. 02, 2024	Feb. 03, 2024
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 1,977.8	$ 1,836.8
Less: Accumulated depreciation	(1,195.9)	(1,080.8)
Property and equipment, net	781.9	756
Machinery and equipment
Property, Plant and Equipment [Line Items]
Property and equipment, gross	1,514.7	1,376.2
Land, buildings, and leasehold improvements
Property, Plant and Equipment [Line Items]
Property and equipment, gross	302.6	312.4
Computer software
Property, Plant and Equipment [Line Items]
Property and equipment, gross	127	116.5
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 33.5	$ 31.7

Supplemental Financial Inform_6

Supplemental Financial Information (in millions) - Other Non-current Assets (Details) - USD ($) $ in Millions	Nov. 02, 2024	Feb. 03, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Prepaid ship and debits	$ 385.7	$ 547.6
Prepayments on supply capacity reservation agreements	$ 288.2	$ 302.5
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]	Other non-current assets	Other non-current assets
Operating right-of-use assets	$ 213.7	$ 203.6
Technology licenses	164	350.6
Non-marketable equity investments	49.4	45.8
Other	64.8	56.8
Other non-current assets	$ 1,165.8	$ 1,506.9

Supplemental Financial Inform_7

Supplemental Financial Information (in millions) - Accrued Liabilities (Details) - USD ($) $ in Millions	Nov. 02, 2024	Feb. 03, 2024
Accrued liabilities:
Variable consideration estimates	$ 468.3	$ 610.7
Accrued restructuring	120.8	16.1
Technology license obligations	47.7	105.7
Lease liabilities - current portion	43.2	39.4
Deferred revenue	34.5	43.2
Accrued income tax payable	33.4	17.8
Accrued interest payable	22.7	41.3
Accrued warranty expense	16.9	25.5
Accrued legal reserve	1.1	76.5
Other	36.6	56.7
Accrued liabilities	$ 825.2	$ 1,032.9

Supplemental Financial Inform_8

Supplemental Financial Information (in millions) - Other Non-current Liabilities (Details) - USD ($) $ in Millions	Nov. 02, 2024	Feb. 03, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Non-current restructuring liabilities	$ 236.9	$ 0.9
Operating Lease, Liability, Statement of Financial Position [Extensible Enumeration]	Other non-current liabilities	Other non-current liabilities
Lease liabilities - non-current	$ 203.2	$ 196
Non-current income tax payable	72	56.6
Deferred tax liabilities	46.3	58.7
Technology license obligations	37	196.5
Other	18.2	15.6
Other non-current liabilities	$ 613.6	$ 524.3

Supplemental Financial Inform_9

Supplemental Financial Information (in millions) - Accumulated Other Comprehensive Loss (Details) - USD ($) $ in Millions	3 Months Ended						9 Months Ended
	Nov. 02, 2024	Aug. 03, 2024	May 04, 2024	Oct. 28, 2023	Jul. 29, 2023	Apr. 29, 2023	Nov. 02, 2024	Oct. 28, 2023
Increase (Decrease) in AOCI Attributable to Parent, Net of Tax [Roll Forward]
Balance at beginning of period	$ 14,204.9	$ 14,478.7	$ 14,831.4	$ 15,389.5	$ 15,493.9	$ 15,637.2	$ 14,831.4	$ 15,637.2
Other comprehensive income (loss), net of tax	0.1	(0.8)	(0.7)	(0.4)	(0.1)	(0.9)	(1.4)	(1.4)
Balance at end of period	13,372.9	$ 14,204.9	14,478.7	15,233.4	$ 15,389.5	15,493.9	13,372.9	15,233.4
Unrealized Gain (Loss) on Cash Flow Hedges
Increase (Decrease) in AOCI Attributable to Parent, Net of Tax [Roll Forward]
Balance at beginning of period			$ 1.1			$ 0	1.1	0
Other comprehensive income (loss) before reclassifications							(0.8)	(3.6)
Amounts reclassified from accumulated other comprehensive income (loss)							(0.6)	2.2
Other comprehensive income (loss), net of tax							(1.4)	(1.4)
Balance at end of period	$ (0.3)			$ (1.4)			$ (0.3)	$ (1.4)